Experiment,Cellname,Library,Anchor,Tissue,Conc,CancerType,Gender,Ethnicity,AgeAtSampling,y_trueIC,y_trueEmax,y_predIC,y_predEmax
7384,SIDM00053,Crizotinib,Dactolisib,Pancreas,0.0125,Pancreatic Ductal Adenocarcinoma,Male,Unknown,52.74992395704158,1.6191989,0.16577408,0.35312251658979327,0.0012187233762596826
108113,SIDM01165,Paclitaxel,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Male,White,56.0,2.2537246,0.2137172,0.2586452426239713,-0.004153156025151664
101234,SIDM01056,Lapatinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,50.0,3.5014799,0.11855192,0.3516713284612536,0.0012187233762596826
70014,SIDM00531,Ruxolitinib,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.7873465,-0.01867746,1.4175453794749793,0.0012187233762596826
24488,SIDM00971,Trametinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.49787778,-0.005972532,-0.8168454621192578,-0.0004654444736829603
50828,SIDM00842,SCH772984,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,55.0,0.39771754,0.04179125,-0.31534057279788064,-0.004153156025151664
40282,SIDM00789,Vinorelbine,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,Unknown,52.74992395704158,-0.81766516,-0.0835681,-0.07571904001535489,-0.004153156025151664
84258,SIDM00842,AZD8055,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,55.0,-2.8377852,-0.091098696,-1.7573217422639695,0.0012187233762596826
5394,SIDM00633,MK-2206,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.91484845,0.03657773,-0.10381050063126226,0.0049064349277283875
88873,SIDM01096,Dabrafenib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,65.0,2.4114106,0.15501134,0.08278638482849325,-0.004153156025151664
34625,SIDM01090,Linsitinib,SCH772984,Large Intestine,0.5,Colon Carcinoma,Unknown,Unknown,52.74992395704158,-1.0559517,-0.052473746,-0.5541748655765026,0.0012187233762596826
71438,SIDM00633,MK-2206,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.21752864,0.0077148406,-0.8133312495006932,0.0012187233762596826
7627,SIDM01165,MK-2206,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,White,56.0,1.8947928,0.13977054,-0.13781843186324336,-0.0004654444736829603
98393,SIDM00950,Paclitaxel,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6749636,-0.041640572,-0.047696420390319114,0.0008671208063046559
104565,SIDM00777,AZD4547,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,55.0,1.4622318,0.15253583,0.2778561930089456,-0.00450475859510669
7070,SIDM00842,SCH772984,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,55.0,1.782798,0.1583793,-0.9787245125992738,-0.004153156025151664
21587,SIDM00774,AZD8055,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,1.1863577,0.07394325,0.30876019813800526,-0.004153156025151664
17254,SIDM01056,5-Fluorouracil,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,50.0,-2.1948268,-0.08455843,-1.4900823723926808,0.0012187233762596826
103761,SIDM00664,5-Fluorouracil,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,White,46.0,1.3777229,0.07923142,0.05018297289587535,0.0012187233762596826
91090,SIDM00453,Erlotinib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,64.0,-0.8897341,-0.06589952,-0.6332035688707112,-0.004153156025151664
73503,SIDM00882,Olaparib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Other,42.0,-1.2539195,-0.030881256,0.6411100765958313,0.0012187233762596826
96029,SIDM00866,Entinostat,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,52.0,2.1019475,0.16237657,0.5429920680412507,-0.004153156025151664
95625,SIDM00148,Cisplatin,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6954859,0.10418819,-0.1933239694328774,-0.004153156025151664
104642,SIDM00097,Nilotinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.62426436,0.06023617,-0.06570910036248562,-0.004153156025151664
64836,SIDM00772,AZD6482,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,38.0,-0.9422148,-0.06301212,0.17427676448034124,0.0008671208063046559
80510,SIDM00332,AZD6482,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.2944361,-0.009370259,-0.9164679483692496,-0.00450475859510669
93374,SIDM00971,SCH772984,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.0215442,-0.08143506,-1.559740091546108,0.0008671208063046559
40174,SIDM01186,ZM447439,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,-3.5915663,-0.16850832,-0.17049663914478425,-0.0004654444736829603
77780,SIDM00049,Camptothecin,SB505124,Large Intestine,2.5,Colorectal Carcinoma,Female,Unknown,46.0,3.072605,0.2437174,0.31667880909559,0.0049064349277283875
16403,SIDM00933,ZM447439,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,2.8416295,0.16079016,-0.6574868270802349,0.0012187233762596826
93007,SIDM00537,5-Fluorouracil,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,71.0,1.0176301,0.09351052,-0.2345062175379241,-0.004153156025151664
76650,SIDM00834,Afatinib,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.7613075,-0.16372944,0.6485454849533868,0.02082694692184988
4176,SIDM01187,Axitinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-3.8330624,-0.18895847,-1.1917249200753086,-0.00450475859510669
96729,SIDM00241,Dabrafenib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,East Asian,53.0,-1.6163006,-0.12849873,-0.2487806527407201,-0.004153156025151664
36688,SIDM00877,5-Fluorouracil,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.76807475,0.040841836,-1.5909862302508668,0.0008671208063046559
25618,SIDM00146,GSK269962A,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.3703427,-0.060862724,-1.5082305182218696,0.0012187233762596826
36786,SIDM00630,Luminespib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,38.0,-1.6570735,-0.043563932,-0.11698670159799102,0.0012187233762596826
30064,SIDM00534,AZD7762,SCH772984,Large Intestine,0.5,Colon Carcinoma,Unknown,Unknown,52.74992395704158,-0.10561458,-0.0069158874,0.17489857053413307,-0.004153156025151664
40466,SIDM00772,Navitoclax,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,38.0,4.4691186,0.20757115,0.2693967615674828,0.0012187233762596826
48295,SIDM00314,MK-1775,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,1.5691445,0.04011176,0.7170823198908076,-0.004153156025151664
46670,SIDM00359,Linsitinib,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.4103167,-0.18037513,-0.5435067136969342,-0.0010326056058638932
7538,SIDM01135,MK-2206,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,52.74992395704158,-1.9875947,-0.11958199,0.8869586713825738,0.0012187233762596826
73162,SIDM00673,Doramapimod,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.5871136,-0.0807603,-0.11177690124937698,0.0012187233762596826
16695,SIDM00963,Palbociclib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,60.0,-0.8152486,-0.030040832,0.7241385584475947,0.0012187233762596826
17999,SIDM00963,Wee1 Inhibitor,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,60.0,-1.9288664,-0.21917363,-2.0703262213503644,-0.004153156025151664
95905,SIDM00866,Vorinostat,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-2.0981276,-0.1529507,1.2835195337905303,-0.004153156025151664
93975,SIDM00885,Temozolomide,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,41.0,2.0642369,0.22250694,1.126684505276713,0.0012187233762596826
93813,SIDM00878,Afatinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.9549857,-0.12336077,-0.7041566953840978,0.0008671208063046559
16115,SIDM00826,Trametinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,4.2768807,0.37635264,1.2421968642498233,0.0012187233762596826
8494,SIDM00629,Linsitinib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,43.0,0.18098885,0.019448878,0.659614690063576,0.0012187233762596826
68886,SIDM00938,Dabrafenib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,58.0,-3.1562877,-0.10097503,1.7110867117134738,0.0012187233762596826
14654,SIDM00097,ZM447439,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6861846,-0.051438116,-1.3434550780101022,-0.004153156025151664
44357,SIDM01062,Wee1 Inhibitor,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,50.0,-0.102977365,-0.009603854,-0.15013257323944593,-0.00450475859510669
98098,SIDM01186,GSK269962A,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,-0.5297382,-0.056735117,0.5690105285997261,-0.004153156025151664
55457,SIDM00892,Navitoclax,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,23.0,-1.7687578,-0.036269818,0.809189185031264,0.0049064349277283875
41660,SIDM00934,SCH772984,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,40.0,1.4427093,0.11016037,0.5622993953873549,-0.004153156025151664
99124,SIDM00928,Venetoclax,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-0.5429881,-0.008958528,0.40194918913029354,-0.00450475859510669
107953,SIDM00920,Lapatinib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,1.9770907,0.111586034,0.35728363242849537,-0.004153156025151664
45937,SIDM00633,Docetaxel,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.9772654,-0.038114678,1.121973864840122,0.006001129785431316
26798,SIDM00132,Irinotecan,OSI-027,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Female,Unknown,61.0,-1.1055908,-0.030035906,0.21105655094495004,0.0012187233762596826
58171,SIDM00630,AZD6482,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,38.0,0.12536645,0.017051002,-0.32136903704661923,-0.00450475859510669
102746,SIDM00455,SCH772984,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.8928993,0.09896964,0.12448752081104116,-0.004153156025151664
15090,SIDM00150,Dabrafenib,Camptothecin,Large Intestine,0.025,Colon Carcinoma,Unknown,Unknown,52.74992395704158,-0.54677975,-0.039134093,-0.02337593651983272,-0.00450475859510669
93306,SIDM00928,Gemcitabine,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-0.5522753,-0.010671885,0.7209851126874963,0.0012187233762596826
11286,SIDM01037,Uprosertib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,62.0,-0.073763005,-0.001721402,-0.337328678628942,0.0008671208063046559
82564,SIDM00777,Palbociclib,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,55.0,1.1268065,0.06974657,1.5960628388935152,0.02082694692184988
20520,SIDM00772,Navitoclax,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,38.0,-2.4954262,-0.081186086,-1.1676184694473517,0.0012187233762596826
17597,SIDM00272,RO-3306,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,48.0,2.6100945,0.20009016,0.9923634746120246,0.0049064349277283875
8330,SIDM00487,Vinorelbine,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,Unknown,52.74992395704158,2.0035486,0.061085496,0.9974661467498475,0.0012187233762596826
81854,SIDM01186,Trametinib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,-1.0394224,-0.103499494,-0.6327991620296893,-0.00450475859510669
72779,SIDM00879,Venetoclax,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,32.0,0.87783736,0.026763726,0.003967165202491845,0.0012187233762596826
106009,SIDM00122,Olaparib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,72.0,-1.0258132,-0.08540002,0.11819275732086473,-0.00450475859510669
96523,SIDM00835,Navitoclax,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-0.74561906,-0.011821876,0.1606706717533554,0.0012187233762596826
59806,SIDM00332,Ribociclib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.1071222,-0.19653027,-0.6913067928962296,-0.004153156025151664
33990,SIDM00214,AZD7762,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,37.0,-2.1865737,-0.10955546,-0.6312348612657587,0.0012187233762596826
14338,SIDM00528,BI-2536,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,40.0,-4.085974,-0.08643337,-1.0745016690400162,-0.004153156025151664
17700,SIDM00241,MK-2206,Palbociclib,Breast,1.0,Breast Carcinoma,Female,East Asian,53.0,0.47921088,0.030217536,-0.03459095789459542,-0.00450475859510669
13153,SIDM01056,AZD8055,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,50.0,0.79033667,0.049892228,0.19151166369395758,-0.004153156025151664
79491,SIDM00963,Alpelisib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,60.0,-0.76331675,-0.018836495,-0.07670771784007178,0.0008671208063046559
28788,SIDM00841,LGK974,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,51.0,3.8202553,0.14345318,1.9032997507068656,0.0049064349277283875
104465,SIDM00885,Gemcitabine,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,41.0,-3.952561,-0.14440453,-0.8773040995000551,-0.004153156025151664
23085,SIDM00866,Palbociclib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-6.933303,-0.25852165,-2.9879028416670534,-0.00450475859510669
39037,SIDM00562,Uprosertib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,46.0,-1.003635,-0.0713503,-0.9061805385122181,-0.00450475859510669
61467,SIDM00882,Linsitinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Other,42.0,-0.5024991,-0.075735964,-0.5448627270973962,-0.004153156025151664
92261,SIDM01090,AZD7762,Palbociclib,Large Intestine,4.0,Colon Carcinoma,Unknown,Unknown,52.74992395704158,-0.8052871,-0.08462728,-0.4143217380859215,0.0012187233762596826
41947,SIDM00097,AZD6482,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.8109138,-0.19958712,-1.3564362071169993,-0.00450475859510669
18603,SIDM01137,Trametinib,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Male,White,70.0,-0.45799574,-0.017093463,-1.0463167275032574,-0.004153156025151664
38830,SIDM00332,Camptothecin,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.74854755,0.034345426,0.08065122226630449,-0.004153156025151664
730,SIDM00963,Dabrafenib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,60.0,-1.7785964,-0.09840572,-0.46572319161707115,0.0012187233762596826
10955,SIDM00772,Dabrafenib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,38.0,0.82549864,0.08222726,-0.42183448936446527,-0.00450475859510669
21678,SIDM00146,Alisertib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.7664055,-0.029030357,0.39790027040803705,0.0012187233762596826
7725,SIDM00359,AZD8055,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.92607486,0.05943905,-0.3800040975625339,0.0012187233762596826
61564,SIDM00944,Dabrafenib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,52.74992395704158,0.4829555,0.04211567,-0.5350599832803652,-0.00450475859510669
89597,SIDM00884,Lapatinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,43.0,2.0390944,0.055588447,1.251619286198575,-0.0004654444736829603
58266,SIDM00633,PD173074,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.81651026,0.018391993,1.491055696463856,0.0012187233762596826
97109,SIDM00928,AZD6482,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-3.0279791,-0.11122754,0.023192940546865007,0.0006292503840199699
16387,SIDM00940,PF-4708671,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,43.0,-0.6879907,-0.01747777,-0.08323096533534895,0.0012187233762596826
49611,SIDM00148,Temozolomide,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.242112,-0.2261192,-0.9969996948506555,-0.004153156025151664
6870,SIDM00898,Bortezomib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,43.0,-0.74825007,-0.023783706,-0.15213077047905452,-0.004153156025151664
80598,SIDM00541,MK-1775,SCH772984,Large Intestine,0.5,Colon Carcinoma,Unknown,Unknown,52.74992395704158,-0.30916435,-0.01691014,-0.830326924716613,0.0012187233762596826
105809,SIDM00841,Crizotinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,51.0,1.0108662,0.044161353,0.6867726772207179,0.007858728252343744
9491,SIDM00882,SCH772984,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Other,42.0,-1.5410311,-0.07563918,-0.9007395493530486,0.0008671208063046559
8976,SIDM01186,Linsitinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,1.5351096,0.085553266,0.17898471283252568,-0.004153156025151664
42141,SIDM00681,BMS-754807,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,54.0,-1.0760857,-0.07875907,-0.1104995043506408,-0.0006810030359088663
83126,SIDM00898,AZD6482,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,43.0,0.3193036,0.00842656,0.7551059840853999,0.0012187233762596826
36189,SIDM00675,BI-2536,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,50.0,1.8082678,0.17839274,1.0893022495547753,0.003006708515559838
7310,SIDM00675,Paclitaxel,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,50.0,-1.2977599,-0.08633166,1.6014531852773315,-0.00450475859510669
86059,SIDM00938,AZD6482,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,58.0,1.6801895,0.14873357,-0.9965987865018114,-0.00450475859510669
65216,SIDM00866,Docetaxel,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.6377478,-0.13833943,-0.5006350950407198,-0.00450475859510669
7279,SIDM00453,Navitoclax,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,64.0,-3.7267063,-0.14614828,-0.24092441919610771,-0.004153156025151664
19946,SIDM00940,Docetaxel,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,43.0,0.73855686,0.068243265,-0.14204191522328447,-0.0010326056058638932
72819,SIDM00874,Tozasertib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,23.0,-0.6903277,-0.06363611,-0.9078107779257572,-0.00450475859510669
11502,SIDM00633,Olaparib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.6184875,0.09820407,0.635406754342676,0.0012187233762596826
84043,SIDM00957,LGK974,Trametinib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,-2.2546952,-0.0995654,-1.3770080391702757,0.0008671208063046559
78403,SIDM00772,Trametinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,38.0,1.5515393,0.06353837,0.04626234357954653,0.0012187233762596826
87211,SIDM00954,BI-2536,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-0.6790918,-0.06987303,0.4514064868642559,-0.004153156025151664
70307,SIDM00216,SCH772984,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,-1.258525,-0.06746976,-0.39861591030025334,-0.004153156025151664
74847,SIDM00664,OSI-027,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Male,White,46.0,2.8275921,0.0813588,1.1876461948797612,0.0012187233762596826
12813,SIDM00934,Navitoclax,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,40.0,1.7431637,0.13836637,-0.29265909783980915,-0.00450475859510669
81054,SIDM00282,Camptothecin,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,55.0,6.889735,0.5831377,0.6153102383840117,0.0012187233762596826
68186,SIDM00118,BMS-754807,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.6365405,-0.054738443,-0.8818832921804487,-0.00450475859510669
30814,SIDM00042,LGK974,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.019623749,-0.0018046235,-0.03748657446881847,-0.004153156025151664
37955,SIDM00892,Wee1 Inhibitor,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,23.0,-0.58464694,-0.031513564,-0.3493646795501061,0.0012187233762596826
103212,SIDM00660,Dabrafenib,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-2.3467023,-0.07451102,-0.8700017099896767,-0.00450475859510669
102278,SIDM00783,MK-2206,Olaparib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,52.74992395704158,-1.1663977,-0.039834555,-0.0511421557416779,0.0008671208063046559
2188,SIDM00954,AZD8055,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-0.25937593,-0.021904344,-1.3407446656540518,-0.00450475859510669
82471,SIDM00934,Palbociclib,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Male,White,40.0,1.1443456,0.0834778,0.1950325866511716,0.0012187233762596826
33439,SIDM00628,JQ1,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-0.926702,-0.063334376,-0.35523380386802395,-0.004153156025151664
65033,SIDM00954,Linsitinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,2.8061044,0.09807768,0.16025660152780505,0.0012187233762596826
80713,SIDM00866,Pictilisib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.4600443,0.12675017,-0.22638428201040367,-0.00450475859510669
93790,SIDM00971,MK-2206,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.6997838,-0.16666281,-1.6831124089921345,0.0008671208063046559
65148,SIDM00097,Axitinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.86663854,-0.07213514,-0.013896318108179288,-0.0004654444736829603
5412,SIDM00675,Axitinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,50.0,0.75181687,0.052310463,-0.915029692370371,-0.00450475859510669
17543,SIDM00835,Linsitinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,73.0,1.1145872,0.1613293,0.19472875786929392,-0.004153156025151664
106010,SIDM00899,AZD7762,Oxaliplatin,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Female,White,62.0,-1.098085,-0.049667615,-0.45743739626069513,0.0012187233762596826
1620,SIDM00950,MK-2206,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.2516046,0.16619673,0.2213526367046473,-0.004153156025151664
91014,SIDM00877,PD173074,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.8116057,-0.048619475,-1.4811168494149607,0.0012187233762596826
107446,SIDM00633,Tozasertib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.600542,-0.044263363,1.805835821320866,0.0012187233762596826
29104,SIDM01002,Navitoclax,Olaparib,Breast,2.5,Breast Carcinoma,Female,White,46.0,0.37405968,0.03285728,-0.09679398201955218,-0.004153156025151664
19565,SIDM00241,Afatinib,MK-2206,Breast,0.25,Breast Carcinoma,Female,East Asian,53.0,1.9057156,0.18987314,-0.14679786840913941,0.0012187233762596826
34164,SIDM00541,Nutlin-3a (-),Afatinib,Large Intestine,1.0,Colon Carcinoma,Unknown,Unknown,52.74992395704158,-1.6781652,-0.07905828,1.5258102296513214,0.0249215129143481
64943,SIDM01186,OSI-027,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,-2.060642,-0.12246259,0.24698259570835635,0.006001129785431316
20633,SIDM00241,KU-55933,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,East Asian,53.0,-0.48834336,-0.02752933,-0.17306945224377998,-0.004153156025151664
17894,SIDM00675,Gemcitabine,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,50.0,-0.9642767,-0.08058875,-0.3808547073198483,-0.00450475859510669
101707,SIDM00660,AZD4547,Vinorelbine,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,32.0,2.084156,0.050575476,2.1859545079437557,0.02082694692184988
56508,SIDM00878,Doramapimod,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,0.93809175,0.05945962,-0.017309120134917002,0.0049064349277283875
49133,SIDM00571,SCH772984,Dasatinib,Pancreas,0.05,Pancreatic Adenosquamous Carcinoma,Male,East Asian,75.0,-0.5846005,-0.035701577,-0.575843581721914,-0.004153156025151664
90553,SIDM01037,BI-2536,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,62.0,-1.1862478,-0.12750281,-0.5282139472627272,-0.00450475859510669
27654,SIDM00874,Paclitaxel,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,23.0,2.0514243,0.13481787,-0.4027655147232708,0.0012187233762596826
55529,SIDM01186,Luminespib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,-2.8803327,-0.16875628,-0.7058219999256816,-0.0004654444736829603
79003,SIDM00879,ZM447439,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,32.0,0.80057734,0.01267936,1.0171536362572262,0.0008671208063046559
58642,SIDM00633,Luminespib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.6729135,0.0719623,0.041063599945447275,-0.004153156025151664
4172,SIDM00241,Wee1 Inhibitor,Docetaxel,Breast,0.001,Breast Carcinoma,Female,East Asian,53.0,0.6226113,0.029510727,-0.6620077635007318,0.0012187233762596826
82281,SIDM00314,Afatinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,-0.8599921,-0.06325299,-0.1573230076560047,-0.004153156025151664
45954,SIDM00537,Dabrafenib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,71.0,0.69740564,0.02125906,0.11075087990345762,0.0012187233762596826
37619,SIDM00772,AZD6482,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,38.0,1.5820425,0.14465779,2.054498250733401,0.02082694692184988
28574,SIDM01042,Uprosertib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2189237,0.1494065,-0.5350945718275557,-0.00450475859510669
13564,SIDM00122,Dabrafenib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,72.0,-1.3783482,-0.06675701,-0.7305533153307542,0.0008671208063046559
95397,SIDM00866,Ribociclib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.9788932,0.092674926,1.4660858540010353,0.0012187233762596826
46394,SIDM00781,Crizotinib,SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Female,East Asian,43.0,-6.0964684,-0.119183406,-4.479748626432773,-0.004153156025151664
69005,SIDM00938,Ribociclib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,58.0,-1.6093651,-0.10178677,-0.044986679281708686,-0.0006810030359088663
40556,SIDM01136,Ruxolitinib,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,85.0,-1.983131,-0.041661337,-1.6370531805791695,0.0012187233762596826
50255,SIDM01062,Nilotinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,50.0,-2.0613735,-0.25343224,-1.4010466611098782,-0.00450475859510669
9409,SIDM01062,BI-2536,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,50.0,1.9718163,0.07224354,-0.13783694054487916,-0.004153156025151664
48741,SIDM01096,AZD8055,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,65.0,-0.7410647,-0.06978384,0.5749535081029974,-0.0004654444736829603
35970,SIDM00150,Afatinib,Taselisib,Large Intestine,1.0,Colon Carcinoma,Unknown,Unknown,52.74992395704158,-1.4530177,-0.057797924,-0.2729839206732275,0.0012187233762596826
77553,SIDM00879,ZM447439,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,32.0,-1.2971585,-0.08222679,-0.04615314265240077,0.0012187233762596826
79941,SIDM00934,Olaparib,Linsitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,40.0,0.8779766,0.08088362,-0.5800944805877565,-0.00450475859510669
63646,SIDM00778,5-Fluorouracil,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-1.3576083,-0.1424068,-0.027078911959945606,-0.004153156025151664
103856,SIDM00670,MK-2206,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,White,64.0,3.4542358,0.12496677,-0.666893494328643,0.0008671208063046559
89724,SIDM00872,Afatinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.9621847,0.08718723,-0.44606402502583303,0.0012187233762596826
98807,SIDM01165,Sorafenib,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,White,56.0,-2.595475,-0.16966304,-0.7634178329802928,-0.004153156025151664
63637,SIDM00933,Gemcitabine,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.54871494,-0.038050696,-0.022077601980392915,0.0049064349277283875
89576,SIDM00833,Palbociclib,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,2.6778164,0.19011614,1.8150374488700458,0.0249215129143481
15121,SIDM00148,5-Fluorouracil,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.7388819,0.07219598,0.0842727445585585,-0.004153156025151664
100264,SIDM00529,Dabrafenib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.1670991,-0.037192494,-0.42328646227240996,0.0006292503840199699
493,SIDM00928,AZD6482,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,0.52771235,0.01313426,2.7333336004212314,0.0249215129143481
23879,SIDM00272,Dabrafenib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,48.0,-1.1872588,-0.04209124,-2.084518190615811,0.0012187233762596826
93127,SIDM00132,Oxaliplatin,Olaparib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Female,Unknown,61.0,0.40340436,0.024118751,0.4025761697634796,0.0012187233762596826
67899,SIDM00928,Gemcitabine,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-1.622988,-0.025131183,0.724742206533338,0.0249215129143481
23320,SIDM01187,MK-2206,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.26043546,0.02542226,-0.7223305478137398,-0.00450475859510669
83875,SIDM00881,Bortezomib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,49.0,1.7604508,0.052018225,1.45167451208962,0.0008671208063046559
26794,SIDM00943,Dasatinib,Paclitaxel,Pancreas,0.025,Pancreatic Ductal Adenocarcinoma,Male,White,56.0,-1.3912883,-0.06714976,0.11303109547136843,-0.00450475859510669
74619,SIDM00772,NU7441,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,38.0,1.0507673,0.049985398,-0.42593219189334486,0.0012187233762596826
22165,SIDM00866,MK-1775,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,5.6456456,0.27897012,1.7749136862936874,0.0012187233762596826
23820,SIDM00529,Wee1 Inhibitor,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-1.3688403,-0.13737191,-1.4793899828575001,-0.004153156025151664
55540,SIDM01165,MK-2206,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,White,56.0,-0.7297194,-0.073600665,0.09936346476412095,-0.004153156025151664
31069,SIDM01186,Uprosertib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,-1.5961099,-0.03845111,-0.3695917042613317,-0.004153156025151664
99009,SIDM00148,Linsitinib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.0510724,-0.05171436,0.6675455211737233,0.0012187233762596826
96514,SIDM00839,Dabrafenib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,56.0,-0.8989218,-0.07957464,-0.06566285477455487,0.0028028060781799357
84097,SIDM00332,NU7441,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.1308756,-0.1790255,-2.004316382522146,-0.004153156025151664
107625,SIDM00875,Doramapimod,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.9300998,-0.06764547,-0.9368261197078573,0.0008671208063046559
4995,SIDM00783,Dabrafenib,Camptothecin,Large Intestine,0.025,Colon Carcinoma,Male,Unknown,52.74992395704158,2.6404703,0.13430361,1.2123360989922092,-0.0006810030359088663
99958,SIDM00633,OSI-027,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.7898943,-0.10336311,-0.7692800669508792,0.0008671208063046559
61319,SIDM00920,JQ1,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.61504704,-0.038252763,-0.14517674825387827,-0.004153156025151664
30932,SIDM01233,Palbociclib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,72.0,-1.8461832,-0.16148178,0.1995555046677705,-0.004153156025151664
46633,SIDM00122,MK-1775,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,72.0,1.7273823,0.03736441,1.7542622131136023,0.0012187233762596826
1918,SIDM00675,PF-4708671,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,50.0,3.7957532,0.35805538,1.000894635042455,0.0012187233762596826
32650,SIDM00875,GSK269962A,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-6.558423,-0.24525385,-0.6608385418804683,-0.004153156025151664
3742,SIDM01188,SCH772984,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,White,57.0,1.9187499,0.19042578,0.7003032904754386,-0.0004654444736829603
34999,SIDM00882,SCH772984,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Other,42.0,1.002196,0.051893517,-0.09059507053959318,0.0012187233762596826
83081,SIDM00301,Trametinib,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,0.6885463,0.01993732,1.2636399206194295,0.0012187233762596826
106012,SIDM00841,BMS-754807,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,51.0,-1.0772234,-0.07153654,-2.051444646031141,-0.00450475859510669
43466,SIDM00938,MK-1775,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,58.0,-3.4501076,-0.10537632,-1.4925672188276544,0.0012187233762596826
20779,SIDM00272,PF-4708671,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,48.0,2.6999426,0.07948719,1.8496014654631336,0.0012187233762596826
56982,SIDM00146,Navitoclax,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,2.9215102,0.14277084,0.6955987175431085,0.0008671208063046559
4831,SIDM00314,Navitoclax,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,-0.46156955,-0.028932342,0.05831065728892432,0.0012187233762596826
17922,SIDM00963,Crizotinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,60.0,3.3955517,0.09032971,1.6160135635796078,0.0008671208063046559
101279,SIDM00628,RO-3306,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-2.2952383,-0.27936208,-2.0535766866339835,-0.004153156025151664
52350,SIDM00487,MK-1775,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,Unknown,52.74992395704158,-2.0746148,-0.17597538,-0.5298555815327324,-0.004153156025151664
61574,SIDM00879,Doramapimod,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,32.0,2.1795793,0.14539406,-0.05031535090729176,0.0049064349277283875
50993,SIDM00541,Afatinib,SCH772984,Large Intestine,0.5,Colon Carcinoma,Unknown,Unknown,52.74992395704158,0.38363287,0.026909608,-0.0698434137212609,-0.004153156025151664
25407,SIDM00214,BMS-754807,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,37.0,5.320699,0.20351164,2.2654113701517904,-0.004153156025151664
4642,SIDM00789,Dabrafenib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,52.74992395704158,2.2296698,0.0624458,0.22717663722840714,0.0012187233762596826
87735,SIDM00148,Crizotinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.23314245,-0.011588112,-1.0693293751577535,0.0012187233762596826
96940,SIDM00833,SCH772984,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,1.4298525,0.0685474,0.5007784830299173,0.0049064349277283875
31411,SIDM00884,PF-4708671,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,43.0,-0.73829275,-0.029780049,0.8055002724490806,0.0049064349277283875
62753,SIDM01001,Navitoclax,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,62.0,0.66888016,0.059284087,-0.6465811642938386,-0.00450475859510669
94960,SIDM00630,Paclitaxel,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,38.0,1.9845159,0.23090686,0.38035995723719734,0.0012187233762596826
34169,SIDM01002,MK-2206,Olaparib,Breast,10.0,Breast Carcinoma,Female,White,46.0,-3.2826264,-0.09191857,-0.4249171332424961,-0.0006810030359088663
18824,SIDM00214,Dabrafenib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,37.0,1.299331,0.08833181,-1.1233411925267596,-0.004153156025151664
58953,SIDM00920,BI-2536,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.6970966,-0.06573737,-0.29509152302925457,-0.004153156025151664
44568,SIDM01186,MK-1775,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,0.56043327,0.019689355,1.111071299865874,0.0012187233762596826
6382,SIDM00866,Crizotinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.9599606,0.027512582,1.07155471339639,0.0008671208063046559
51544,SIDM00971,Pictilisib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.15404163,-0.014615217,-0.5138984488027781,-0.004153156025151664
33214,SIDM00872,Bortezomib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.64697933,-0.05513606,0.6673072261477826,-0.004153156025151664
878,SIDM00933,Luminespib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,1.4355459,0.11643276,2.439253773936522,0.02082694692184988
36112,SIDM00411,SCH772984,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,-2.9789734,-0.1736983,-2.750342922407292,-0.0010326056058638932
84810,SIDM00833,Dabrafenib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-0.9449095,-0.061773628,-0.7600388146129663,-0.00450475859510669
78812,SIDM01138,SCH772984,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,White,65.0,-0.4326434,-0.037691344,-0.19837601015670575,0.0049064349277283875
48858,SIDM00529,AZD7762,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,-1.2543015,-0.06744838,-0.7447093937333972,0.0012187233762596826
72658,SIDM00875,JQ1,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.645028,-0.052539576,-0.3453697762402284,-0.004153156025151664
61844,SIDM01037,Temozolomide,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,62.0,1.9184899,0.027136425,1.532811999835816,0.0012187233762596826
10195,SIDM01062,Vorinostat,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,50.0,1.7408208,0.101338446,1.4959802054203948,0.0249215129143481
91665,SIDM00673,Ribociclib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.3999227,0.07088779,-0.13076207473324858,-0.004153156025151664
48645,SIDM00453,Olaparib,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,64.0,-3.9340699,-0.08979369,-0.5962479525224162,0.0006292503840199699
77411,SIDM00664,Linsitinib,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Male,White,46.0,0.8090771,0.057215624,3.0112100219863644,0.02082694692184988
36773,SIDM00630,Olaparib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,38.0,5.263864,0.138159,0.38014806625089065,0.0049064349277283875
95961,SIDM00879,MK-2206,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,32.0,-2.0354333,-0.15169665,-1.5677477247010232,-0.00450475859510669
40774,SIDM00453,Lapatinib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,64.0,1.6183081,0.031023083,1.3109099733174967,0.0008671208063046559
82161,SIDM00898,PF-4708671,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,43.0,-2.895233,-0.112739384,0.6826512888551525,0.0049064349277283875
74861,SIDM00359,Crizotinib,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.10671876,-0.0021005739,-0.17624353737782414,0.0012187233762596826
25894,SIDM00885,Bortezomib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,41.0,-2.4244425,-0.07473509,-1.0413401259808879,0.0012187233762596826
34631,SIDM00882,Temozolomide,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Other,42.0,1.2338315,0.06093516,-0.07552375494902513,0.0012187233762596826
79591,SIDM00885,Olaparib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,41.0,-1.0315248,-0.08461107,-0.113001331488362,-0.004153156025151664
27856,SIDM00531,Sorafenib,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.92575,-0.055335805,-0.3421193169943025,0.0012187233762596826
42173,SIDM01137,Dactolisib,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Male,White,70.0,0.9211382,0.062616356,-0.14225881764422255,0.0012187233762596826
93341,SIDM01188,Navitoclax,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,White,57.0,1.9443074,0.051965035,0.9350514726916471,0.0012187233762596826
1424,SIDM00835,Linsitinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,2.219056,0.061096918,2.17473248160744,0.0012187233762596826
70929,SIDM00933,Wee1 Inhibitor,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-1.1711218,-0.052657202,-1.1954234375918278,0.0012187233762596826
108120,SIDM00777,Dabrafenib,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,55.0,-3.4168916,-0.15116479,-1.2154523424576682,0.0012187233762596826
23424,SIDM00216,MK-1775,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.7088585,-0.029470025,-0.1573191299998565,-0.0004654444736829603
80309,SIDM00529,Venetoclax,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.2562622,-0.053736877,-1.3196309128176889,0.0012187233762596826
25772,SIDM00301,MK-2206,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.785028,-0.12238426,-1.164183372357883,-0.00450475859510669
94403,SIDM00898,5-Fluorouracil,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,43.0,-1.0896825,-0.019314347,0.9293250081878816,0.0008671208063046559
22209,SIDM00135,5-Fluorouracil,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.64914805,0.038655575,-1.3941716673732043,-0.0006810030359088663
92044,SIDM00629,Pictilisib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,43.0,-0.6951208,-0.07307849,-0.541025837199788,-0.00450475859510669
72592,SIDM00957,LGK974,MK-2206,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,0.20712322,0.0043286313,2.3359812626532537,0.0049064349277283875
5563,SIDM00954,Wee1 Inhibitor,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,5.5498652,0.4682428,2.354838456752315,0.0012187233762596826
26939,SIDM00779,SB505124,Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,0.19327149,0.0019831664,1.745341758156943,0.0012187233762596826
6151,SIDM00193,Olaparib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.3749114,-0.048181675,-0.7024748348545562,-0.004153156025151664
78235,SIDM00241,Olaparib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,East Asian,53.0,-0.87956864,-0.07783352,-0.5550227350787461,-0.00450475859510669
91030,SIDM00934,Oxaliplatin,Ruxolitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,40.0,2.527871,0.05367031,2.543009239380909,0.0012187233762596826
84190,SIDM00772,Trametinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,38.0,0.650967,0.058474783,-1.4386740496342199,-0.004153156025151664
36532,SIDM00885,AZD8055,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,41.0,0.73188704,0.051464636,0.48732335316926356,0.0012187233762596826
92657,SIDM01056,Bortezomib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,50.0,-1.0995575,-0.042894244,0.498801955231883,-0.004153156025151664
43449,SIDM00933,Sorafenib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,1.4035087,0.08517419,0.6289646615695481,0.0012187233762596826
71554,SIDM00053,Irinotecan,AZD7762,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,Unknown,52.74992395704158,1.7233338,0.19830355,0.7273634645793827,-0.004153156025151664
64179,SIDM00314,Docetaxel,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,2.3405466,0.14363305,0.7356804639193545,0.0049064349277283875
5660,SIDM00629,Lapatinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,43.0,-2.7225282,-0.07781319,1.0486019950616996,0.0249215129143481
26276,SIDM00872,AZD6482,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.69977057,-0.020954428,-0.5133183966664714,0.0012187233762596826
31717,SIDM00146,Dabrafenib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-2.5231462,-0.15480329,-1.10067610843178,0.0008671208063046559
105153,SIDM00933,Uprosertib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,2.0798032,0.19344872,0.14703693853893732,-0.0010326056058638932
57953,SIDM00882,Luminespib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Other,42.0,0.40096104,0.01785492,-0.8762595235706487,-0.00450475859510669
106429,SIDM00272,Venetoclax,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,48.0,0.89581436,0.018736063,0.8397600123549409,0.0012187233762596826
81136,SIDM00879,KU-55933,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,32.0,2.9262145,0.2376744,-0.4399323248345803,0.0012187233762596826
5244,SIDM00833,Afatinib,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-2.1044405,-0.15389755,-2.198996336720988,-0.00450475859510669
76247,SIDM00527,LGK974,Linsitinib,Large Intestine,1.0,Colon Carcinoma,Unknown,Unknown,52.74992395704158,-1.021832,-0.09300659,-1.2172217753698547,-0.00450475859510669
47157,SIDM00146,AZD6482,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.0647179,-0.015113656,1.3093192504809195,0.0012187233762596826
98966,SIDM00529,Tozasertib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,1.3468736,0.052316282,0.1329808477342323,-0.004153156025151664
65516,SIDM00135,PF-4708671,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.24846637,0.026352169,-0.42270810772468087,0.0008671208063046559
25458,SIDM00878,Sorafenib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.8525117,-0.07112539,-0.32040904609453197,-0.004153156025151664
72400,SIDM00920,AZD8055,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.4693378,0.09967766,0.11955561902681637,0.0008671208063046559
30836,SIDM00878,Entinostat,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.608461,-0.014191451,-1.473966226947059,-0.004153156025151664
53116,SIDM00833,AZD4547,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,-1.4348938,-0.060703505,-0.4210152386526944,-0.004153156025151664
99147,SIDM01037,Uprosertib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,62.0,-1.8517145,-0.17784026,-1.6284449767929352,-0.00450475859510669
8511,SIDM00097,NU7441,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6437039,-0.078939565,0.24913613230584739,0.0012187233762596826
63365,SIDM00628,Nilotinib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.487635,0.035882134,0.0949776678195781,-0.004153156025151664
49779,SIDM01186,AZD7762,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,1.6350102,0.10907208,0.31164273376460255,-0.00450475859510669
45755,SIDM00940,Luminespib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,43.0,6.0118895,0.46492684,0.7469919693643887,0.0012187233762596826
93455,SIDM00097,PF-4708671,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,4.5752244,0.23633799,3.3457794439123614,0.0249215129143481
68356,SIDM00148,Nutlin-3a (-),PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.68745947,0.046237793,0.33517088442757625,0.0012187233762596826
7862,SIDM00772,Navitoclax,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,38.0,0.6127984,0.029228896,0.2808937265615675,-0.004153156025151664
50601,SIDM00122,Crizotinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,72.0,-2.2512672,-0.049562287,-1.9871675494858996,0.0008671208063046559
87904,SIDM00529,GSK269962A,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.4539662,-0.0014864875,-1.1151554069031524,-0.00450475859510669
106173,SIDM00885,Uprosertib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,41.0,-1.7246045,-0.063817084,0.9353894141461389,0.014242193916840305
65079,SIDM00680,Linsitinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,58.0,-0.79064614,-0.046870325,-1.1187472514595702,0.0008671208063046559
37817,SIDM00146,Entinostat,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.76327115,0.10604129,-0.6568356587997112,-0.00450475859510669
92325,SIDM01187,Pictilisib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.5731313,-0.14514206,-0.676476168017946,-0.00450475859510669
45202,SIDM00963,AZD7762,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,60.0,1.6786991,0.13697642,0.4675351958885205,-0.004153156025151664
72412,SIDM00498,Palbociclib,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Female,East Asian,77.0,0.2022416,0.014233426,0.258450818406141,0.0012187233762596826
38703,SIDM00882,Temozolomide,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Other,42.0,-1.7085134,-0.09869959,-0.9422136339143514,-0.004153156025151664
2391,SIDM00332,5-Fluorouracil,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.786262,-0.07854813,0.49078102231933995,0.0049064349277283875
24886,SIDM00314,Gemcitabine,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,0.11575738,0.008325249,-0.5948684479087123,-0.00450475859510669
10917,SIDM00884,Alisertib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,43.0,-0.28952864,-0.021388542,-0.21511063540764747,-0.00450475859510669
96967,SIDM00884,Lapatinib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,43.0,1.4634743,0.059496,-0.4032122497157624,0.0012187233762596826
81675,SIDM01056,Temozolomide,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,50.0,-0.79637545,-0.060688224,0.06431884400797723,-0.004153156025151664
25385,SIDM00332,GSK269962A,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.48387468,-0.03321901,-0.6050297892088691,0.0008671208063046559
6447,SIDM00122,MK-1775,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,72.0,-0.55812144,-0.04363888,-1.2807065880024,0.0008671208063046559
13415,SIDM00455,Gemcitabine,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.821431,0.029274842,0.4342934163371902,0.0008671208063046559
21066,SIDM00866,SCH772984,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,3.632312,0.06910478,1.896095432366539,0.0012187233762596826
7975,SIDM00832,SB505124,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,1.7536983,0.13566832,-0.04807733706854395,-0.0004654444736829603
79916,SIDM00371,MK-1775,Paclitaxel,Pancreas,0.025,Pancreatic Ductal Adenocarcinoma,Male,East Asian,73.0,-3.4202912,-0.0392902,-0.17410441264840731,-0.004153156025151664
20579,SIDM00681,BMS-754807,Afatinib,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,54.0,-0.3711938,-0.009810218,0.30017539356595757,0.0012187233762596826
39129,SIDM00241,Taselisib,PD173074,Breast,2.5,Breast Carcinoma,Female,East Asian,53.0,-2.706262,-0.14806429,-0.6225778772310242,0.0012187233762596826
36072,SIDM00453,Irinotecan,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,64.0,0.91941774,0.06772781,-1.0761636353042736,-0.00450475859510669
21787,SIDM00130,Palbociclib,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.8740833,-0.0911606,0.1419715117426287,-0.0004654444736829603
70749,SIDM01186,AZD8055,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,1.5458839,0.12017258,-0.5038766629926229,0.0012187233762596826
39035,SIDM00146,Docetaxel,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-1.4451028,-0.056849934,-1.4489494703738044,0.0012187233762596826
24501,SIDM00779,5-Fluorouracil,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,0.5676558,0.020631067,0.7047974397402508,-0.004153156025151664
37441,SIDM00469,Linsitinib,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,Unknown,52.74992395704158,2.3501723,0.17558393,-0.24208527122771395,0.0012187233762596826
94371,SIDM00893,Alisertib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,4.300811,0.3769549,1.7136818480140972,0.014242193916840305
83053,SIDM00673,AZD8055,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,3.995751,0.09192622,0.5086932230946789,0.0008671208063046559
68896,SIDM00938,NU7441,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,58.0,-2.3899255,-0.05197561,0.07648479619090214,0.0008671208063046559
19519,SIDM01165,Oxaliplatin,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,White,56.0,4.4913363,0.19494644,0.30535067915176634,0.0012187233762596826
93464,SIDM00783,AZD8055,MK-2206,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,52.74992395704158,3.9863977,0.22820988,0.4169672792225395,-0.004153156025151664
7282,SIDM01002,AZD7762,Pictilisib,Breast,0.5,Breast Carcinoma,Female,White,46.0,-2.502647,-0.14219162,-0.5773211085006837,-0.004153156025151664
19742,SIDM00301,Oxaliplatin,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-0.792854,-0.06327077,-0.9582810056541458,-0.004153156025151664
85380,SIDM00933,Bortezomib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-2.2205632,-0.062213488,0.19100044720770795,0.0049064349277283875
78985,SIDM00097,AZD8055,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.70683026,-0.046160504,-0.5732449034419331,-0.00450475859510669
93612,SIDM00893,OSI-027,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.70772713,0.05196555,-0.6167801368385508,0.0008671208063046559
32098,SIDM00241,Alpelisib,MK-2206,Breast,1.0,Breast Carcinoma,Female,East Asian,53.0,0.56913227,0.057368807,-1.2680457605646658,-0.004153156025151664
88367,SIDM00681,Taselisib,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,54.0,-3.2772405,-0.18849036,-1.5049357954663445,-0.004153156025151664
88681,SIDM00583,Crizotinib,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,56.0,-1.755114,-0.09776936,0.31060677556737515,-0.0006810030359088663
95143,SIDM00899,Cisplatin,Crizotinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Female,White,62.0,4.404958,0.29857513,0.03979241245510879,0.0012187233762596826
93708,SIDM00675,MK-1775,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,50.0,-0.5934862,-0.03423742,-0.5106798070950643,-0.004153156025151664
46055,SIDM00527,Navitoclax,AZD4547,Large Intestine,10.0,Colon Carcinoma,Unknown,Unknown,52.74992395704158,1.1419739,0.08172623,-0.518447724256057,-0.0006810030359088663
33682,SIDM00314,Paclitaxel,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,2.8162835,0.11996804,1.6828110176786335,0.0008671208063046559
92188,SIDM00878,SCH772984,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,1.7740878,0.111258745,1.036789455409627,-0.004153156025151664
47582,SIDM00839,Linsitinib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,56.0,1.5976254,0.020666907,-0.0594548304549741,-0.004153156025151664
105388,SIDM00630,Pictilisib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,38.0,-2.4583747,-0.06646519,-2.20581756382937,0.0012187233762596826
76823,SIDM00781,Vinorelbine,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Female,East Asian,43.0,-1.7795558,-0.07926304,0.01639817234164746,0.0008671208063046559
99955,SIDM00779,Vinorelbine,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,1.4992374,0.121211596,0.8356734904031504,0.0012187233762596826
9421,SIDM01037,Docetaxel,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,62.0,0.5588974,0.04299243,-0.07634516894038022,-0.004153156025151664
4005,SIDM00884,Paclitaxel,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,43.0,-4.144063,-0.19330005,-0.533242125302792,-0.00450475859510669
1563,SIDM00971,AZD7762,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.7941987,0.059141185,-0.22703069823195154,0.0012187233762596826
87764,SIDM00874,Tozasertib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,23.0,1.7621968,0.08608831,0.9752548982595103,0.0008671208063046559
98450,SIDM00122,Vorinostat,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,72.0,0.24655908,0.021577869,-0.1248212449788718,-0.004153156025151664
67642,SIDM00314,5-Fluorouracil,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,1.9578544,0.11191658,-0.24554223162856276,0.0012187233762596826
35004,SIDM00148,Docetaxel,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.23226425,-0.028187588,-0.29570846699230474,-0.00450475859510669
15731,SIDM00314,Navitoclax,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,0.55075985,0.013705618,0.698020577666148,0.0012187233762596826
22357,SIDM00783,5-Fluorouracil,SB505124,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,52.74992395704158,-0.5935431,-0.037782248,-0.11683023253290127,0.0012187233762596826
1532,SIDM00675,Trametinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,50.0,1.0369264,0.022960693,3.2178680167555087,0.0049064349277283875
93085,SIDM00505,Trametinib,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,65.0,0.7732815,0.0563923,-0.06652116303503947,-0.0010326056058638932
65780,SIDM00675,Navitoclax,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,50.0,0.30449566,0.013627447,-1.0832038029003856,-0.00450475859510669
74768,SIDM01062,Docetaxel,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,50.0,-1.8763857,-0.116679214,-0.4851527478004467,-0.004153156025151664
40446,SIDM00583,OSI-027,Dasatinib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,56.0,4.01704,0.08347897,1.3228846284103903,0.0012187233762596826
61872,SIDM00135,SCH772984,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.53063333,-0.013359261,0.5305571744431666,0.006001129785431316
82233,SIDM01187,Pictilisib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,4.7800403,0.23853731,2.5415859885035577,0.0249215129143481
101609,SIDM01056,Gemcitabine,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,50.0,2.8827808,0.3393755,2.496136610617695,0.0049064349277283875
71826,SIDM00928,Vorinostat,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-0.95118797,-0.075468175,-0.9995900648445493,-0.00450475859510669
79873,SIDM01037,5-Fluorouracil,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,62.0,-2.0292828,-0.07589017,-1.121671720740604,-0.0010326056058638932
65088,SIDM00877,Alisertib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-0.99287236,-0.0644028,-1.5404235154463422,-0.00450475859510669
68883,SIDM01233,MK-2206,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,-1.078103,-0.051755052,0.21308661111617608,0.0006292503840199699
268,SIDM00874,RO-3306,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,23.0,1.2168455,0.0258945,0.8449726160493003,0.0008671208063046559
16149,SIDM00879,Tozasertib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,32.0,-1.7157338,-0.056776997,-2.469048869502887,0.0008671208063046559
92466,SIDM00875,JQ1,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1309953,0.094904706,1.0259377726800916,0.0008671208063046559
53047,SIDM01096,Vinorelbine,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,65.0,-3.057982,-0.20696846,-1.2519457752301508,-0.004153156025151664
45946,SIDM00898,Palbociclib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,43.0,0.94758826,0.07662877,-0.5454877828267582,0.0012187233762596826
16785,SIDM00877,BI-2536,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-2.9754796,-0.23218732,-0.058727482797144126,0.0008671208063046559
17257,SIDM00314,Ribociclib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,0.92167133,0.08213417,1.9110953038185592,0.013303823686337351
84886,SIDM00877,Camptothecin,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-0.45592052,-0.013309503,-0.7523287161545962,-0.004153156025151664
21327,SIDM00630,SCH772984,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,38.0,6.123416,0.14263028,0.8273608386834606,-0.004153156025151664
26987,SIDM00562,Ribociclib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,46.0,-1.1907691,-0.07257477,-0.7730221063306109,-0.004153156025151664
18691,SIDM00148,Nutlin-3a (-),OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.2295046,-0.02266419,0.4789186666896286,-0.004153156025151664
67895,SIDM00877,KU-55933,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.7209554,-0.067689225,-0.656809483440707,-0.00450475859510669
106047,SIDM00872,Afatinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3195981,-0.1388011,-0.382490777661724,-0.00450475859510669
82748,SIDM00878,AZD8055,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.2426199,-0.100554936,-0.5331237566482754,-0.00450475859510669
16425,SIDM00469,Cisplatin,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Male,Unknown,52.74992395704158,3.1087885,0.292023,-0.7284977680749379,0.0008671208063046559
65068,SIDM00628,Lapatinib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,2.253234,0.105547726,-0.052155823591885024,0.0012187233762596826
36219,SIDM00943,Cisplatin,Erlotinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,56.0,-0.4625404,-0.02343209,0.38147915675324057,-0.0004654444736829603
38858,SIDM00954,Venetoclax,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,1.9872762,0.06009504,-0.7144102332886683,-0.004153156025151664
87262,SIDM00826,Trametinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-1.5252765,-0.13813545,-1.3511308365801085,-0.004153156025151664
19850,SIDM00779,Nutlin-3a (-),5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,0.68813753,0.066338025,-0.2870073946428632,-0.004153156025151664
106023,SIDM00136,AZD7762,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,44.0,-1.545417,-0.07606038,2.009945923326565,0.009831670697094548
33050,SIDM00940,MK-2206,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,43.0,1.2495127,0.074508265,0.7271358009557993,0.0006292503840199699
76781,SIDM00834,Trametinib,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.2059251,-0.12649384,0.30013023465042904,-0.00450475859510669
71586,SIDM01001,MK-2206,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,62.0,1.8138198,0.1407632,0.19148762406541742,-0.004153156025151664
97191,SIDM00097,Cisplatin,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,4.0023146,0.18471082,1.9929639033586832,0.0049064349277283875
45447,SIDM00529,Lapatinib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.39114508,-0.024831627,0.5138693253315274,0.0049064349277283875
2775,SIDM00940,AZD8055,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,43.0,-5.390063,-0.20603399,0.8990005541431573,0.0006292503840199699
91135,SIDM00097,Crizotinib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,6.2294765,0.22278824,2.597391835132673,0.02082694692184988
70748,SIDM00193,Trametinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.69985443,0.030272257,1.671791609649671,-0.004153156025151664
28076,SIDM00673,Wee1 Inhibitor,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.61475134,-0.07230575,0.12987551810794196,-0.00450475859510669
18715,SIDM00835,SB505124,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-0.8891858,-0.013697227,0.9494172157377581,0.0012187233762596826
94062,SIDM00537,MK-1775,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,71.0,1.7085541,0.064649075,-0.3630440007609098,0.0008671208063046559
9756,SIDM00272,Temozolomide,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,48.0,-1.6349647,-0.038755357,-2.2725312734941965,-0.004153156025151664
81753,SIDM00629,ZM447439,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,43.0,-3.7520702,-0.19548641,0.0946181426153244,-0.004153156025151664
76840,SIDM00837,Taselisib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-1.5905433,-0.09395482,-1.670380978234793,-0.00450475859510669
47282,SIDM00933,SCH772984,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.0877861,0.087033644,-0.7734476994735935,-0.004153156025151664
95656,SIDM00630,PD173074,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,38.0,-1.1688907,-0.017824885,-0.29158474572042087,0.0008671208063046559
17550,SIDM00877,OSI-027,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,2.6280372,0.067479976,1.5857177828967388,0.006001129785431316
107918,SIDM00877,Afatinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,4.5876174,0.10938768,1.8043718479528765,0.0012187233762596826
20164,SIDM00892,MK-2206,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,23.0,3.4935265,0.29786178,0.2908818965450643,-0.004153156025151664
73189,SIDM00879,Dabrafenib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,32.0,-3.2115762,-0.1943339,-1.0396421353196013,0.0008671208063046559
1507,SIDM00892,Cisplatin,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,23.0,2.286537,0.18260528,0.6221199978138781,-0.004153156025151664
60551,SIDM00878,Cisplatin,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-1.404791,-0.052586216,-0.019946535719223484,-0.004153156025151664
10079,SIDM00097,Venetoclax,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.3503575,0.0076314504,1.166210847982155,0.0012187233762596826
66906,SIDM00920,MK-1775,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.18305497,-0.0047186506,0.32840451093453227,0.0012187233762596826
29269,SIDM01187,Docetaxel,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.6542137,0.122180216,-0.2883098828407715,0.0049064349277283875
42619,SIDM00898,Wee1 Inhibitor,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,43.0,3.8473775,0.07235503,2.956155131830504,0.02082694692184988
83076,SIDM00879,SCH772984,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,32.0,2.7737095,0.10367976,0.558176430626568,0.0012187233762596826
85035,SIDM00314,MK-2206,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,-1.1493896,-0.073126845,-0.9889733250910993,-0.004153156025151664
4731,SIDM00680,BMS-754807,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,58.0,0.28515542,0.009041632,0.9263608686578494,0.0012187233762596826
74472,SIDM00633,Palbociclib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.4289992,0.21473427,0.41700471679130724,0.0049064349277283875
53988,SIDM00842,BMS-754807,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,55.0,-2.1454308,-0.0734279,-0.7144791528088846,-0.004153156025151664
20115,SIDM00541,Taselisib,BMS-754807,Large Intestine,0.05,Colon Carcinoma,Unknown,Unknown,52.74992395704158,-1.6148275,-0.12562573,0.1832476473741716,-0.0006810030359088663
92626,SIDM00527,AZD4547,SCH772984,Large Intestine,0.5,Colon Carcinoma,Unknown,Unknown,52.74992395704158,0.5305767,0.04464976,0.9184296112746508,-0.004153156025151664
79920,SIDM00633,Paclitaxel,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.614161,0.069412775,0.28985396459077856,0.0012187233762596826
2371,SIDM00892,Nilotinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,23.0,3.0286374,0.18814856,0.2488060546351733,0.0008671208063046559
80108,SIDM00531,Gemcitabine,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.60583645,0.027222553,0.6701252487145902,0.0008671208063046559
41175,SIDM01062,NU7441,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,50.0,-2.499005,-0.19890614,-0.24281239620016298,-0.004153156025151664
27401,SIDM00898,NU7441,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,43.0,-1.9253788,-0.11824618,-1.364913573674096,-0.004153156025151664
54800,SIDM00132,LGK974,Lapatinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Female,Unknown,61.0,-0.49005347,-0.005901912,-0.12287857478003139,-0.004153156025151664
6495,SIDM00878,JQ1,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.20159648,-0.013810444,0.7427241049590841,-0.0006810030359088663
106171,SIDM00628,Afatinib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.58674866,0.030467274,-0.8494302858649518,0.0012187233762596826
56628,SIDM00498,AZD4547,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Female,East Asian,77.0,0.67908597,0.044738285,-0.16157043184649977,-0.004153156025151664
57540,SIDM00866,BI-2536,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,0.758993,0.07655677,-0.9841261864495714,-0.00450475859510669
101510,SIDM00411,Dactolisib,5-Fluorouracil,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.9137224,0.02733995,1.9181345090274449,0.02082694692184988
88589,SIDM00774,OSI-027,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.0035055,0.074612945,0.5814037769115938,0.0012187233762596826
36406,SIDM00882,Navitoclax,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Other,42.0,-1.8096205,-0.09298486,-0.46114621466381595,0.0012187233762596826
59036,SIDM01090,AZD7762,Oxaliplatin,Large Intestine,5.0,Colon Carcinoma,Unknown,Unknown,52.74992395704158,-0.65590173,-0.042839676,-1.4298169431928958,-0.00450475859510669
70157,SIDM00541,MK-2206,AZD4547,Large Intestine,10.0,Colon Carcinoma,Unknown,Unknown,52.74992395704158,-2.830085,-0.090345785,-2.975908782260174,0.0008671208063046559
11750,SIDM00630,Navitoclax,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,38.0,-0.3975178,-0.048721977,0.31058647036644915,-0.00450475859510669
22040,SIDM00455,Navitoclax,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.11700096,0.0038592312,-0.18831780210705912,0.0008671208063046559
15448,SIDM00884,GSK269962A,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,43.0,-1.4044553,-0.06052526,-0.8840729749947278,0.0012187233762596826
32699,SIDM00371,AZD7762,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,East Asian,73.0,0.70858043,0.07410648,-0.4113024336012155,-0.004153156025151664
55771,SIDM00898,Nilotinib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,43.0,-4.904207,-0.16671585,-2.9101170384755957,0.0008671208063046559
34820,SIDM01056,OSI-027,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,50.0,5.90864,0.20031777,4.103277059094681,-0.004153156025151664
95382,SIDM00527,Linsitinib,MK-1775,Large Intestine,1.0,Colon Carcinoma,Unknown,Unknown,52.74992395704158,-0.26053214,-0.017949173,-0.7929111362941295,-0.00450475859510669
15668,SIDM00875,Luminespib,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.8649713,-0.079975516,1.0568271949814398,-0.004153156025151664
81542,SIDM01037,Nutlin-3a (-),Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,62.0,-0.4240156,-0.044376634,0.18769164772166186,-0.004153156025151664
4437,SIDM00885,5-Fluorouracil,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,41.0,1.9083139,0.06702183,1.3946245618894821,0.0008671208063046559
21431,SIDM01001,Bortezomib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,62.0,0.74459195,0.06376344,0.36860765507055426,-0.004153156025151664
51391,SIDM00772,Luminespib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,38.0,-1.1887876,-0.050998777,-0.4470968717339315,0.0008671208063046559
103696,SIDM00097,Dabrafenib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8692882,0.18183155,0.5515457526736044,-0.004153156025151664
42126,SIDM00943,MK-1775,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,56.0,1.2798125,0.03815756,0.8802877106200175,0.0008671208063046559
3747,SIDM00660,MK-2206,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,0.8995862,0.048408866,0.6602492977537073,0.0049064349277283875
16065,SIDM00881,Camptothecin,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,49.0,-1.4559834,-0.13385813,-0.2556368442050741,-0.004153156025151664
81444,SIDM00629,GSK269962A,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,43.0,-2.4281065,-0.12381666,-1.8537613399383837,0.0012187233762596826
50341,SIDM00781,BMS-754807,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Female,East Asian,43.0,-3.2610497,-0.11456096,-0.4956326013014144,-0.004153156025151664
3229,SIDM00875,Docetaxel,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3009373,0.08519313,1.2930172731755425,0.02082694692184988
81866,SIDM00875,Tozasertib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.1951836,0.00976932,-0.5320921672543312,0.0049064349277283875
5826,SIDM00892,Tozasertib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,23.0,-1.7045974,-0.08595343,-1.6974735759865085,-0.0010326056058638932
89436,SIDM00872,Nilotinib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.3720516,0.040037826,0.4214617080270321,0.0008671208063046559
38147,SIDM00453,AZD7762,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,64.0,0.1921329,0.0046681035,0.5153934223524832,0.0012187233762596826
20113,SIDM00562,Nilotinib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,46.0,-1.7268411,-0.061512306,-0.1191159246510861,0.0008671208063046559
82212,SIDM00774,AZD8055,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.40084273,0.037475128,1.0072842896390442,0.0012187233762596826
83551,SIDM00150,Vinorelbine,5-Fluorouracil,Large Intestine,10.0,Colon Carcinoma,Unknown,Unknown,52.74992395704158,0.39815986,0.01154733,0.7278473172771602,0.0012187233762596826
58750,SIDM00664,Taselisib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,White,46.0,1.4067274,0.09234739,0.4750314112184529,-0.004153156025151664
61220,SIDM00892,Navitoclax,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,23.0,0.8299375,0.108381994,-0.9085712306004335,-0.004153156025151664
54248,SIDM00498,SCH772984,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Female,East Asian,77.0,0.8048006,0.023910487,0.3242358198733136,0.0012187233762596826
83528,SIDM00135,Palbociclib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.5980186,0.09960315,0.13803033455322303,0.0012187233762596826
48429,SIDM00214,Crizotinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,37.0,-2.5306318,-0.07401591,0.18608798979991736,0.0008671208063046559
18096,SIDM00314,Navitoclax,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,1.509457,0.047016013,1.5252020531037016,0.0012187233762596826
32867,SIDM00772,Navitoclax,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,38.0,1.2458264,0.06335785,0.7937453557858665,0.0249215129143481
105668,SIDM00633,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.7019345,0.017955761,0.09925612860562777,0.0012187233762596826
19790,SIDM00675,Alisertib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,50.0,2.0429895,0.06020728,-0.6733381201809013,-0.004153156025151664
31669,SIDM00950,Sorafenib,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7036872,-0.07735574,-0.027571796977006794,-0.004153156025151664
83933,SIDM00136,5-Fluorouracil,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,44.0,-2.5009243,-0.13936783,-0.6770153809031051,-0.004153156025151664
71787,SIDM00884,Uprosertib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,43.0,-0.50559586,-0.036124934,-0.6339958055054241,-0.00450475859510669
27488,SIDM00146,OSI-027,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.8558359,-0.0787544,-2.136209213112538,-0.00450475859510669
104966,SIDM00677,MK-2206,Camptothecin,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,63.0,0.4030446,0.011450011,0.5941967441917954,0.006001129785431316
50111,SIDM00971,Nutlin-3a (-),MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4162369,-0.04775694,0.9691611333374699,0.0012187233762596826
55039,SIDM01188,Ruxolitinib,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,White,57.0,0.7806675,0.07034877,-0.34604424777328685,-0.00450475859510669
49239,SIDM00537,AZD8055,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,71.0,-0.35754773,-0.0337172,-0.7346021140621586,-0.004153156025151664
65177,SIDM01042,Luminespib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4428747,-0.054003615,-0.04865661790458147,0.0012187233762596826
103679,SIDM00675,Dabrafenib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,50.0,-2.62853,-0.06716914,-0.5524303986994298,0.0012187233762596826
235,SIDM00562,Alisertib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,46.0,2.0883434,0.051750336,-0.47288123066148113,-0.00450475859510669
52270,SIDM00877,Tozasertib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,2.0095572,0.07387817,2.170541973757327,0.0008671208063046559
98732,SIDM00537,MK-1775,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,71.0,0.86346537,0.060224116,0.7520920524956386,0.0012187233762596826
22317,SIDM00777,Afatinib,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,55.0,-3.5602262,-0.15281516,-0.8993698877001121,-0.004153156025151664
89360,SIDM00193,AZD8055,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.68805885,0.0129508525,0.8794567607145939,0.0008671208063046559
26086,SIDM01056,KU-55933,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,50.0,-1.3384492,-0.07069968,0.1432481775386665,0.0012187233762596826
79035,SIDM00892,RO-3306,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,23.0,-1.2532519,-0.034582097,-0.6250044355638213,0.0012187233762596826
108155,SIDM00097,GSK269962A,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0810983,-0.04079954,-2.058864842903372,0.0012187233762596826
22111,SIDM00884,Ribociclib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,43.0,0.6358927,0.0376445,-0.00305245052504626,-0.00450475859510669
93227,SIDM00842,Olaparib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,55.0,-0.77544993,-0.079740755,0.018809777130981576,-0.00450475859510669
57809,SIDM00898,AZD7762,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,43.0,-3.6980088,-0.1184682,-2.3815328976295627,0.0012187233762596826
44107,SIDM00314,Taselisib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,1.3034239,0.1119128,-0.25014842193996845,-0.004153156025151664
86700,SIDM00872,Navitoclax,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.023960887,-0.0014170255,-0.8334726719463698,-0.00450475859510669
14741,SIDM00562,Paclitaxel,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,46.0,0.74903125,0.027960908,-0.07168493734457036,0.0008671208063046559
56768,SIDM00841,AZD7762,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,51.0,1.5661389,0.1482616,0.48211531353342685,0.0012187233762596826
48806,SIDM01002,Palbociclib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,White,46.0,-2.160617,-0.06555215,-0.15276954788740144,0.0012187233762596826
55471,SIDM00963,ZM447439,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,60.0,-1.8167303,-0.15510659,-0.93434837044595,-0.00450475859510669
73860,SIDM00314,Alisertib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,0.68133706,0.034437828,0.3666311752751834,0.0049064349277283875
107819,SIDM00562,Nutlin-3a (-),Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,46.0,-0.9675058,-0.038354784,-0.7377864623565649,0.0008671208063046559
56033,SIDM00892,SCH772984,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,23.0,-1.0966574,-0.10399912,-0.6491429646184895,-0.00450475859510669
56757,SIDM00272,Camptothecin,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,48.0,1.303563,0.107937865,-0.5279977141299407,0.0008671208063046559
58192,SIDM00933,JQ1,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.24640621,-0.013694651,0.25460892057903045,-0.004153156025151664
22358,SIDM01056,MK-2206,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,50.0,2.5523803,0.11878517,1.0678315885776615,0.0012187233762596826
82389,SIDM00832,Vinorelbine,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,81.0,4.975451,0.3096294,0.8442945445725313,0.0008671208063046559
53975,SIDM00272,Entinostat,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,48.0,-0.3338173,-0.02235003,-0.9453511046965752,-0.00450475859510669
9396,SIDM00681,Nutlin-3a (-),Afatinib,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,54.0,0.7934667,0.051396687,1.8551967738354447,0.02082694692184988
3268,SIDM00774,PF-4708671,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.6747856,-0.12395079,-1.3824311751886118,-0.00450475859510669
91075,SIDM00488,Navitoclax,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,Unknown,52.74992395704158,-0.68253684,-0.053150635,2.2024357027650945,0.0006292503840199699
84045,SIDM00097,AZD7762,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.2661166,0.08643422,1.292153969163667,0.0012187233762596826
23090,SIDM00892,Entinostat,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,23.0,1.2702533,0.0787278,0.25008641250583313,0.0012187233762596826
62166,SIDM01096,Taselisib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,65.0,3.3303192,0.25504518,-0.9980863841401556,-0.004153156025151664
21153,SIDM00216,Dabrafenib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,2.0748928,0.0324298,2.0127956687410857,0.006001129785431316
61012,SIDM00241,PD173074,Docetaxel,Breast,0.001,Breast Carcinoma,Female,East Asian,53.0,0.43098962,0.0345699,-0.4247924761223387,-0.0006810030359088663
63462,SIDM00505,Erlotinib,Trametinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,65.0,-1.2345519,-0.07766794,-0.7984641531816801,-0.004153156025151664
35696,SIDM00680,Trametinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,58.0,-1.3014498,-0.05975249,-0.9144615138520436,0.0008671208063046559
60241,SIDM00920,ZM447439,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,4.537062,0.20527974,1.7867728565578085,0.0249215129143481
73326,SIDM00628,Navitoclax,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-0.50779295,-0.014791694,-1.2154339166753316,-0.004153156025151664
63893,SIDM00148,Ribociclib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.07751331,-0.006337657,0.4045493281404782,-0.004153156025151664
19247,SIDM00834,Trametinib,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,White,66.0,-0.59106576,-0.03536427,0.01934796462561768,-0.004153156025151664
97539,SIDM00963,Dabrafenib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,60.0,-1.7716017,-0.16511334,-0.6060251656542197,-0.004153156025151664
100367,SIDM00582,LGK974,Navitoclax,Pancreas,1.0,Pancreatic Carcinoma,Female,East Asian,65.0,0.3796264,0.025544152,0.9906382447489346,0.0012187233762596826
56512,SIDM00455,Gemcitabine,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.1916159,-0.055379875,-0.28150214346902447,0.0012187233762596826
98965,SIDM00146,Paclitaxel,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-2.2918174,-0.06691587,-1.4973015951112951,-0.004153156025151664
166,SIDM00332,Palbociclib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.948259,0.09152461,-0.04471725889039934,-0.0004654444736829603
17632,SIDM00872,Vorinostat,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.673445,-0.08847168,-0.3471733519053141,0.0012187233762596826
33877,SIDM00677,AZD4547,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,63.0,-1.6312759,-0.06904045,0.4080898298466773,0.0012187233762596826
53136,SIDM00533,Dactolisib,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,66.0,-0.7210473,-0.08530935,-0.6268910457946827,-0.004153156025151664
86202,SIDM00241,Venetoclax,Taselisib,Breast,0.1,Breast Carcinoma,Female,East Asian,53.0,1.3987155,0.11178021,-0.9762719326756881,0.0049064349277283875
80898,SIDM00629,Nilotinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,43.0,-2.2543914,-0.11807195,-1.6098090912855838,0.0008671208063046559
57229,SIDM00411,Taselisib,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.103028655,-0.004399793,-0.20903090653032386,0.0012187233762596826
45603,SIDM00529,Entinostat,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-1.4750072,-0.104318194,-0.6944955632102364,-0.0004654444736829603
72314,SIDM00630,Ribociclib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,38.0,-1.2509643,-0.110919654,-1.0769933581639406,-0.00450475859510669
83983,SIDM00933,Trametinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,1.3804063,0.14160703,-1.6920895186273712,-0.004153156025151664
105585,SIDM00583,Cisplatin,MK-1775,Pancreas,0.2,Pancreatic Ductal Adenocarcinoma,Male,White,56.0,3.0120366,0.23462032,-0.506308582053087,0.0012187233762596826
71706,SIDM01062,Entinostat,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,50.0,-0.97489995,-0.06043528,0.8340992383952509,0.0012187233762596826
82182,SIDM00533,Sorafenib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,66.0,1.2554938,0.13584219,0.38731393460215285,-0.004153156025151664
74957,SIDM00469,Erlotinib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,Unknown,52.74992395704158,-1.5404913,-0.118611954,-0.15530237494990812,-0.00450475859510669
84613,SIDM00884,GSK269962A,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,43.0,-2.5894833,-0.111718744,-1.2381192328169703,-0.00450475859510669
50318,SIDM00957,Dabrafenib,5-Fluorouracil,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-2.400035,-0.12212089,0.263533292340183,0.0012187233762596826
50461,SIDM01135,SCH772984,Palbociclib,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,52.74992395704158,-0.7506259,-0.014568514,-0.062236931898350945,0.0012187233762596826
92582,SIDM00841,Crizotinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,51.0,2.633895,0.22120908,0.2629549168833618,0.0008671208063046559
7199,SIDM01233,Vinorelbine,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,-3.4242773,-0.19216403,-0.9159441445704192,-0.00450475859510669
94044,SIDM00453,MK-1775,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,64.0,3.248772,0.064869426,1.9337128000496728,0.02082694692184988
74204,SIDM00272,Doramapimod,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,48.0,-3.1592922,-0.059269823,-1.5990011139985256,0.0008671208063046559
58588,SIDM00049,AZD7762,AZD4547,Large Intestine,10.0,Colorectal Carcinoma,Female,Unknown,46.0,-0.7993001,-0.023367936,-0.3218113072238305,-0.004153156025151664
38367,SIDM01090,Navitoclax,Camptothecin,Large Intestine,0.025,Colon Carcinoma,Unknown,Unknown,52.74992395704158,-1.8136914,-0.035587687,-0.6952712971328735,0.0008671208063046559
69626,SIDM00053,Cisplatin,Dactolisib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,Unknown,52.74992395704158,1.8143512,0.078033425,-0.21408462319945182,0.0012187233762596826
11752,SIDM01037,Cisplatin,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,62.0,-1.8625971,-0.097571164,-1.767024306075282,0.0012187233762596826
23762,SIDM00582,Oxaliplatin,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Female,East Asian,65.0,-2.0213594,-0.12776506,-1.1368647428606884,-0.004153156025151664
13360,SIDM00371,Paclitaxel,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,East Asian,73.0,-2.134813,-0.108753756,-0.024094007687119567,-0.0004654444736829603
78248,SIDM00950,Crizotinib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0431008,-0.017627602,0.9305704445554639,0.0012187233762596826
45335,SIDM01056,AZD7762,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,50.0,-0.38710615,-0.017408706,-0.02551272829777822,0.0012187233762596826
80365,SIDM00136,SCH772984,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,44.0,-1.4238566,-0.17003606,-1.9809155230077486,-0.004153156025151664
107471,SIDM00783,AZD8055,Linsitinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,52.74992395704158,-0.47238338,-0.040178724,-0.7222147262310497,-0.004153156025151664
102304,SIDM00135,MK-2206,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.035259,0.18898837,1.353479712931324,-0.00450475859510669
99398,SIDM00629,Axitinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,43.0,4.4733677,0.111056134,2.9424939939059613,0.0049064349277283875
52500,SIDM00940,Paclitaxel,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,43.0,-0.13112818,-0.0057862005,-0.08582126009421091,0.0012187233762596826
77323,SIDM00933,MK-1775,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.1687878,0.027597161,1.1598621678958416,0.0008671208063046559
92197,SIDM00833,Camptothecin,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,2.4021623,0.06348966,0.7169837173813739,0.0012187233762596826
4327,SIDM00893,Uprosertib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.928971,-0.041037913,0.7800370363779978,-0.0006810030359088663
84001,SIDM00469,Navitoclax,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Male,Unknown,52.74992395704158,3.7831,0.34213865,-0.19490104438888947,0.0012187233762596826
87616,SIDM00878,BI-2536,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,0.8400619,0.07382241,-0.2325149936493147,0.0008671208063046559
77697,SIDM00148,AZD8055,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.4019924,-0.017207244,-0.19582444777339453,-0.0004654444736829603
24642,SIDM00875,Cisplatin,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1302843,-0.052503068,-1.1246801492205973,-0.004153156025151664
4063,SIDM00469,SCH772984,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,Unknown,52.74992395704158,-0.9611957,-0.08670814,-0.1923082419864078,-0.004153156025151664
61299,SIDM00878,RO-3306,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,2.8055813,0.11489845,1.2791369398634087,0.0012187233762596826
64297,SIDM00963,Venetoclax,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,60.0,-0.46676874,-0.018348835,-1.7343084127675754,-0.004153156025151664
3763,SIDM00832,Linsitinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,81.0,0.52630806,0.020272229,0.4841007847392995,0.0012187233762596826
97636,SIDM00633,Uprosertib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.2858231,-0.025963059,1.3106378539931536,0.02082694692184988
3127,SIDM00049,Nutlin-3a (-),Camptothecin,Large Intestine,0.0025,Colorectal Carcinoma,Female,Unknown,46.0,0.7644978,0.018913874,0.4502123201574681,0.0012187233762596826
83175,SIDM00533,5-Fluorouracil,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,66.0,-1.3094662,-0.035330944,0.7909661644595101,0.0049064349277283875
102975,SIDM00664,Erlotinib,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Male,White,46.0,0.84693646,0.05066637,-0.916668205857439,-0.004153156025151664
102437,SIDM00272,Tozasertib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,48.0,1.211331,0.10904968,0.21970821866057322,-0.00450475859510669
46461,SIDM00963,BI-2536,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,60.0,-0.6617986,-0.0645145,-0.5898812998711125,-0.00450475859510669
82074,SIDM00874,PD173074,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,23.0,-2.2563803,-0.072007135,-0.9008951805373966,0.0012187233762596826
86923,SIDM00778,Navitoclax,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,69.0,-2.0528195,-0.15313807,-2.742286123510903,-0.00450475859510669
87937,SIDM00487,AZD7762,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5283979,-0.14815418,-0.5091712207294842,0.0012187233762596826
104316,SIDM00097,Cisplatin,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1751494,-0.031604137,0.43985829509164776,0.0012187233762596826
63143,SIDM00053,Navitoclax,Dactolisib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,Unknown,52.74992395704158,0.6303922,0.055171166,-1.0860801149682346,-0.004153156025151664
62289,SIDM00774,KU-55933,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-1.5185213,-0.08286976,-0.8208142342363817,-0.00450475859510669
107451,SIDM00963,MK-2206,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,60.0,-2.3539038,-0.16235812,1.278947728525348,-0.00450475859510669
104400,SIDM00772,PD173074,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,38.0,1.7689312,0.09804301,1.5500901276625993,0.0012187233762596826
100535,SIDM00963,Trametinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,60.0,-2.2030442,-0.12079687,-1.9296360057735995,0.0008671208063046559
36463,SIDM00122,Doramapimod,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,72.0,0.78529835,0.061996326,-0.9210608480840162,-0.004153156025151664
18816,SIDM00136,AZD8055,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,44.0,1.6865612,0.092857204,-1.3810034513190665,-0.004153156025151664
13467,SIDM00629,MK-1775,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,43.0,0.23410021,0.012945655,0.2736822420110821,-0.004153156025151664
42540,SIDM00132,Dasatinib,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Female,Unknown,61.0,4.126425,0.09106057,1.0105672503044523,0.02082694692184988
64523,SIDM00498,LGK974,AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Female,East Asian,77.0,-1.2369841,-0.08553095,-0.5546857691779272,-0.00450475859510669
58987,SIDM00839,Camptothecin,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,56.0,2.9224112,0.2521952,-0.32488291989167656,0.0008671208063046559
44252,SIDM00882,Taselisib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Other,42.0,0.42921337,0.07335407,0.10782587448866691,-0.00450475859510669
22124,SIDM00781,AZD4547,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Female,East Asian,43.0,-1.2628286,-0.07626301,-0.6441444514001492,-0.00450475859510669
67012,SIDM01137,Linsitinib,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,70.0,-1.608508,-0.1378475,-0.37489329250168685,-0.00450475859510669
41840,SIDM00487,LGK974,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8286136,-0.061949126,0.48921729139650477,0.0249215129143481
52039,SIDM01139,Crizotinib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,White,70.0,1.121875,0.047695603,0.9341303460605147,0.0012187233762596826
68914,SIDM00673,JQ1,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,1.0777278,0.0660062,-2.1208740719245602,-0.00450475859510669
77691,SIDM01037,NU7441,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,62.0,0.13273065,0.015462521,-0.3215109566837703,-0.004153156025151664
86863,SIDM00582,OSI-027,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Female,East Asian,65.0,-0.594702,-0.062009335,0.22033340655687378,-0.004153156025151664
24578,SIDM00772,AZD7762,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,38.0,-1.765656,-0.14900601,-0.5860362877411474,-0.00450475859510669
15156,SIDM00877,ZM447439,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,5.1036773,0.21231043,0.7437872161053997,0.0012187233762596826
105369,SIDM00301,SCH772984,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,3.4318473,0.0901715,2.1587565880100406,0.0012187233762596826
66982,SIDM00834,SB505124,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,White,66.0,2.610136,0.10563238,1.707076933138534,-0.004153156025151664
25292,SIDM01186,Entinostat,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,-0.47298622,-0.037033033,-0.1637548782476301,-0.004153156025151664
9847,SIDM00675,Uprosertib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,50.0,-0.2992074,-0.020913567,0.7688983948578353,-0.0004654444736829603
82278,SIDM00675,Bortezomib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,50.0,-0.62840194,-0.04028903,-0.8365031772254643,-0.00450475859510669
61014,SIDM00835,SCH772984,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-2.8496423,-0.12994963,-1.1398449477435333,0.0012187233762596826
16134,SIDM01096,AZD7762,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,65.0,3.25152,0.18979533,1.5991814543099532,0.0008671208063046559
19362,SIDM00789,SCH772984,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,52.74992395704158,2.5311365,0.22087695,0.048382214371995254,0.0008671208063046559
13647,SIDM01090,Olaparib,Linsitinib,Large Intestine,10.0,Colon Carcinoma,Unknown,Unknown,52.74992395704158,1.8761082,0.108872764,0.1163494325876476,0.0049064349277283875
77828,SIDM00633,GSK269962A,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0010668,-0.037669525,-1.343999522310975,0.0008671208063046559
2383,SIDM00533,OSI-027,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,66.0,0.028337918,0.000838562,-0.637840701501848,-0.00450475859510669
62584,SIDM00531,Palbociclib,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.0755582,0.0965399,1.0709135185662841,0.0049064349277283875
53523,SIDM00893,Gemcitabine,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.0564587,0.09718278,2.1418644127477076,0.0008671208063046559
54732,SIDM00411,Palbociclib,5-Fluorouracil,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.2833201,0.17278744,-1.241500472657256,-0.004153156025151664
85367,SIDM01165,Navitoclax,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,White,56.0,-2.581259,-0.06985523,-0.36107885042540977,-0.00450475859510669
71299,SIDM00528,BI-2536,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,40.0,0.25058657,0.01964782,-1.1332714163394013,-0.004153156025151664
13789,SIDM00781,Navitoclax,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Female,East Asian,43.0,0.71496093,0.015734568,1.5794650230683887,0.0012187233762596826
71354,SIDM00920,Tozasertib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.63428944,0.04415664,0.12283115117270108,0.0008671208063046559
56340,SIDM00950,Trametinib,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.5207433,0.08067249,-0.5717532009698283,0.0008671208063046559
100348,SIDM00583,Dactolisib,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,56.0,-0.640211,-0.0104178265,1.6922319315166408,0.0008671208063046559
8518,SIDM00892,MK-1775,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,23.0,-0.4096154,-0.0081791,0.3931925198124155,0.0012187233762596826
57327,SIDM00455,Oxaliplatin,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.7220354,0.047506988,-0.18324577111307436,0.0049064349277283875
7014,SIDM01186,Doramapimod,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,-1.279219,-0.12050381,-2.04562499023877,-0.004153156025151664
89321,SIDM00631,Lapatinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,White,43.0,-2.3175426,-0.103485346,-1.088122216672989,-0.0004654444736829603
105801,SIDM00583,Paclitaxel,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,56.0,-0.399288,-0.0034107524,1.7379274509596263,0.0249215129143481
50360,SIDM00772,Sorafenib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,38.0,-0.931472,-0.08243107,-0.05855944738604376,-0.004153156025151664
8913,SIDM00872,Axitinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.91874754,-0.013893084,0.037094464202933414,0.0008671208063046559
33205,SIDM00881,PD173074,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,49.0,-1.1984661,-0.09653881,-0.3922325133893534,-0.004153156025151664
73123,SIDM00453,5-Fluorouracil,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,64.0,1.9355503,0.15776056,0.4071246394547337,0.0012187233762596826
30272,SIDM00879,Pictilisib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,32.0,-3.9175642,-0.17603815,-1.5920178669521179,-0.004153156025151664
81832,SIDM00537,SCH772984,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,71.0,2.801035,0.14121294,-1.4895172002394725,0.0012187233762596826
84982,SIDM00782,Afatinib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,-0.45123196,-0.024690075,-0.05986260785397635,-0.004153156025151664
87085,SIDM00954,Alisertib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,1.2406105,0.039901905,0.14784355020727852,0.0012187233762596826
5448,SIDM00777,Nutlin-3a (-),SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,55.0,-2.5836797,-0.187295,-1.1373216956867107,-0.004153156025151664
60085,SIDM00920,5-Fluorouracil,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.80754834,0.043350298,-0.3776807765804272,-0.004153156025151664
34556,SIDM00833,Trametinib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,0.22378242,0.01784466,-0.3949497585664576,-0.004153156025151664
89772,SIDM00963,Sorafenib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,60.0,1.0794752,0.08282607,-0.46896966411360974,-0.004153156025151664
3071,SIDM01042,AZD7762,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.5807562,0.12452612,0.4893344440006165,0.0049064349277283875
20325,SIDM00122,Luminespib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,72.0,0.94312316,0.10060115,0.25792666422065386,-0.004153156025151664
14041,SIDM00272,Tozasertib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,48.0,-0.7733867,-0.08852305,-0.24714368432156117,-0.00450475859510669
62460,SIDM00789,Camptothecin,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,52.74992395704158,-1.9840996,-0.16862386,-0.008436777429021304,-0.00450475859510669
87213,SIDM00940,Nutlin-3a (-),Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,43.0,0.51959014,0.03684865,0.41969349044026877,-0.004153156025151664
43830,SIDM00537,Navitoclax,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,71.0,1.556676,0.09881369,0.17497660635676082,-0.004153156025151664
23776,SIDM00971,Alisertib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4563494,-0.03251428,-0.7254448151113635,0.0012187233762596826
44005,SIDM00870,Nutlin-3a (-),Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,82.0,-1.6232817,-0.11143977,-1.061327751007228,-0.00450475859510669
71783,SIDM01001,Palbociclib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,62.0,-0.5478748,-0.056313828,-0.7638044777269869,-0.00450475859510669
13860,SIDM00781,Linsitinib,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Female,East Asian,43.0,1.1565926,0.080351405,0.5558762032784932,-0.0004654444736829603
85114,SIDM00528,Gemcitabine,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,40.0,-0.35478166,-0.048493918,-0.11939387570927742,-0.004153156025151664
51205,SIDM00681,Oxaliplatin,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,54.0,-1.6706781,-0.035879638,-0.11431973535673345,0.0008671208063046559
27542,SIDM01186,JQ1,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,-2.5891063,-0.11901492,-2.6080925403180557,0.0012187233762596826
40454,SIDM00681,LGK974,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,54.0,-0.712632,-0.05475798,-0.34461269939885963,-0.004153156025151664
9405,SIDM00841,MK-1775,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,51.0,-0.6338876,-0.020872585,0.11249217124712457,0.0008671208063046559
106861,SIDM01197,Palbociclib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,1.803177,0.17822541,-1.1823105202901936,0.0012187233762596826
53761,SIDM01187,Temozolomide,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.30245012,-0.017220542,-0.4339502664636798,-0.004153156025151664
48342,SIDM00875,SCH772984,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.2685786,0.026516305,-0.5234717056889763,-0.004153156025151664
25947,SIDM00571,Paclitaxel,Palbociclib,Pancreas,2.0,Pancreatic Adenosquamous Carcinoma,Male,East Asian,75.0,-2.0212724,-0.08365957,-2.150459570799654,0.0008671208063046559
26157,SIDM00954,Sorafenib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,3.862765,0.034661934,0.8248935621619325,-0.004153156025151664
31607,SIDM00872,AZD7762,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,5.234675,0.23561235,0.44829517688427534,-0.004153156025151664
90884,SIDM00789,MK-2206,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,52.74992395704158,0.8073068,0.04807194,1.1327540976576325,0.0008671208063046559
19290,SIDM00097,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.25512776,0.008354529,0.6417073292984222,0.0012187233762596826
103261,SIDM01096,AZD7762,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,65.0,-1.6157321,-0.08924282,-0.939988485359101,-0.0006810030359088663
27560,SIDM00776,Taselisib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,0.30833367,0.0054079695,0.9885169839522517,0.0012187233762596826
90728,SIDM00963,Luminespib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,60.0,1.5832193,0.13135324,0.3585642470644496,0.0012187233762596826
19904,SIDM01136,Trametinib,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,85.0,0.8212372,0.05509351,-0.12245182605558215,0.0012187233762596826
39585,SIDM00875,Doramapimod,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.26105985,-0.024353603,-0.17552877064809316,-0.00450475859510669
95162,SIDM00282,MK-2206,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-2.1603675,-0.12604707,-0.05104824586853582,0.0012187233762596826
7798,SIDM00411,Navitoclax,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.9781234,0.26543537,-0.30856916114303296,-0.004153156025151664
65044,SIDM00892,Temozolomide,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,23.0,-1.3447716,-0.048422437,-0.21014845131984933,0.0012187233762596826
7063,SIDM00630,PF-4708671,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,38.0,0.5980469,0.024797799,0.4200528975133093,0.0012187233762596826
9915,SIDM00528,Pictilisib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,40.0,0.47192985,0.013159815,-0.0029313950710391926,0.0008671208063046559
76419,SIDM00680,Vinorelbine,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,58.0,-1.5443352,-0.06281645,-0.6119755911350069,0.0008671208063046559
46054,SIDM01136,Crizotinib,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,85.0,-3.4776762,-0.090445444,-0.20519594072785205,0.0012187233762596826
104411,SIDM00371,Irinotecan,Crizotinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,East Asian,73.0,-1.592595,-0.09115063,0.24639912897986932,-0.0010326056058638932
98145,SIDM00498,AZD4547,Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Female,East Asian,77.0,1.4358215,0.17418566,0.7961952910119214,-0.0004654444736829603
84513,SIDM00537,Vinorelbine,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,71.0,0.55606675,0.051651176,-0.5996362149871465,-0.004153156025151664
36500,SIDM00834,AZD8055,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,2.8566966,0.07255432,1.2344434859649807,-0.0004654444736829603
102683,SIDM00132,Gemcitabine,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Female,Unknown,61.0,-2.5298722,-0.10387526,-1.0052926790741998,0.0012187233762596826
52142,SIDM00118,Oxaliplatin,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.3430054,-0.020001972,0.4367042554064693,-0.004153156025151664
21649,SIDM00529,AZD8055,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-2.6468265,-0.06565566,0.6514861864244238,0.014242193916840305
46095,SIDM00680,Olaparib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,58.0,2.3640785,0.105569504,1.5798489690594912,0.0012187233762596826
8701,SIDM00498,5-Fluorouracil,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Female,East Asian,77.0,-0.8224049,-0.042272978,-1.2841012177949105,-0.0006810030359088663
97957,SIDM00531,Lapatinib,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.8697693,0.13902895,2.8483105869689456,0.0249215129143481
70470,SIDM00898,Tozasertib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,43.0,-4.019353,-0.2526983,-2.1231316181319273,-0.00450475859510669
87972,SIDM00628,AZD7762,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-2.3514652,-0.06065536,-1.131789647976258,-0.0006810030359088663
84146,SIDM01062,Pictilisib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,50.0,-1.5446391,-0.052569624,-2.060819894024874,0.0012187233762596826
11668,SIDM00633,Wee1 Inhibitor,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.6111324,0.063098654,1.8580569802847786,0.0012187233762596826
48788,SIDM00528,NU7441,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,40.0,0.60312575,0.020344771,-0.758931052162107,0.0049064349277283875
9637,SIDM00928,Taselisib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,35.0,0.42007524,0.044576574,-1.4555573247300504,-0.004153156025151664
17317,SIDM00488,Olaparib,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Male,Unknown,52.74992395704158,-1.0566894,-0.08537635,0.09349113607230757,-0.004153156025151664
100626,SIDM00943,Taselisib,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,56.0,-1.7573316,-0.1522659,-0.26768213167938676,-0.004153156025151664
53240,SIDM00898,Wee1 Inhibitor,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,43.0,-0.915786,-0.04164415,0.10016512064479291,-0.004153156025151664
36519,SIDM01037,KU-55933,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,62.0,-1.741463,-0.03295627,0.6086549525984757,0.0012187233762596826
26685,SIDM00943,SCH772984,MK-2206,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,56.0,-1.5779902,-0.04253087,1.2833131532984718,0.0012187233762596826
60405,SIDM01138,Ruxolitinib,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,White,65.0,-2.8146644,-0.073271014,-0.7674038879538179,-0.004153156025151664
85566,SIDM00150,AZD4547,Afatinib,Large Intestine,1.0,Colon Carcinoma,Unknown,Unknown,52.74992395704158,3.1912985,0.16061403,-0.19145422128121597,-0.004153156025151664
88729,SIDM00670,Paclitaxel,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,White,64.0,-1.0389411,-0.09591098,-1.0244226452362781,-0.00450475859510669
90085,SIDM00874,MK-2206,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,23.0,0.80300313,0.050327092,-0.4112681536083713,-0.00450475859510669
91165,SIDM00866,Lapatinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,1.2805946,0.040972542,0.9156276490455099,0.0012187233762596826
41434,SIDM01188,Dasatinib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,White,57.0,-1.1401447,-0.11889076,-0.26122756527204294,-0.00450475859510669
4058,SIDM00893,MK-2206,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.524894,-0.108886264,0.17718757965118684,0.0008671208063046559
8231,SIDM00673,Camptothecin,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,0.7929099,0.030326976,-0.8263024450059936,0.0012187233762596826
140,SIDM00933,Paclitaxel,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,2.8016205,0.056991823,1.8428237037528996,0.003006708515559838
38525,SIDM01186,Doramapimod,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,-1.3136715,-0.094298035,-0.22215621859265877,-0.004153156025151664
49811,SIDM00928,Crizotinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,1.873903,0.03274771,0.42592549280181424,-0.004153156025151664
67349,SIDM00898,5-Fluorouracil,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,43.0,-2.7640524,-0.077937804,1.18636101888918,0.0249215129143481
58760,SIDM00812,5-Fluorouracil,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,53.0,2.3354375,0.18552078,1.4581440830176051,0.0012187233762596826
45358,SIDM00571,LGK974,Oxaliplatin,Pancreas,2.5,Pancreatic Adenosquamous Carcinoma,Male,East Asian,75.0,1.8462099,0.10047431,0.00434349502633612,0.0012187233762596826
40351,SIDM00882,GSK269962A,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Other,42.0,-1.5524715,-0.117689505,-0.6687140525840345,-0.00450475859510669
1292,SIDM00505,Paclitaxel,Gemcitabine,Pancreas,0.1,Pancreatic Ductal Adenocarcinoma,Male,White,65.0,0.22781259,0.0069551165,0.6568993191564577,0.0008671208063046559
7872,SIDM00631,Axitinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,White,43.0,-1.0460324,-0.047822207,-0.04945269804129981,-0.00450475859510669
41766,SIDM00774,Temozolomide,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.7554114,-0.07365589,0.5599091782212242,0.0006292503840199699
20469,SIDM00214,Linsitinib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,37.0,-1.377311,-0.114274,-0.7793975087000159,-0.00450475859510669
83147,SIDM01135,MK-2206,Lapatinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,52.74992395704158,-1.5467845,-0.0968232,-0.7702194666825021,-0.004153156025151664
19033,SIDM00042,Linsitinib,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.7885139,-0.07254352,-0.7727935132121431,-0.004153156025151664
16674,SIDM00533,AZD7762,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,66.0,4.4440794,0.22366296,-1.7590018186946537,0.0008671208063046559
93547,SIDM00928,Nutlin-3a (-),Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-1.1888726,-0.038383093,-0.8870056636676682,0.0012187233762596826
48322,SIDM00527,SCH772984,Trametinib,Large Intestine,0.1,Colon Carcinoma,Unknown,Unknown,52.74992395704158,2.1286027,0.16190258,-0.6430964490523937,0.0008671208063046559
61569,SIDM00359,5-Fluorouracil,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0545038,0.20027052,1.1940609490534853,-0.004153156025151664
16755,SIDM00136,AZD4547,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,44.0,-1.4896381,-0.07433079,-0.524575191781325,-0.004153156025151664
102106,SIDM00875,Afatinib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6986691,-0.09384025,-0.43228650948566816,-0.004153156025151664
100540,SIDM00881,JQ1,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,49.0,5.620881,0.35845393,2.2519062195392965,0.0249215129143481
32415,SIDM01062,Bortezomib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,50.0,-1.7991546,-0.041020133,-1.1607662842096127,0.0008671208063046559
103148,SIDM00042,Irinotecan,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.51155084,-0.043429766,-0.8226921508975642,-0.004153156025151664
12679,SIDM00118,SB505124,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.6911578,0.019857422,0.8671434501580093,-0.004153156025151664
88627,SIDM00541,LGK974,Crizotinib,Large Intestine,0.625,Colon Carcinoma,Unknown,Unknown,52.74992395704158,-0.8014543,-0.054604247,-0.4788325504641272,-0.004153156025151664
80673,SIDM00833,AZD8055,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-3.328533,-0.074877165,-1.9890647933012036,0.0008671208063046559
18339,SIDM00505,Trametinib,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,65.0,-0.5164695,-0.055638943,-0.06612958393031498,-0.004153156025151664
48482,SIDM00216,SB505124,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.8155181,-0.15001987,0.3388805482827193,-0.00450475859510669
54807,SIDM00877,OSI-027,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-1.5274274,-0.116513595,-0.9773750163664123,-0.004153156025151664
3248,SIDM00928,PF-4708671,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,0.90295696,0.067825206,-0.3585428373808961,0.0008671208063046559
42110,SIDM00774,Palbociclib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.900254,-0.19438672,-0.06996747659239493,-0.004153156025151664
59761,SIDM00866,Olaparib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-2.8437026,-0.18975766,-0.16577693540347835,-0.004153156025151664
52717,SIDM00971,AZD8055,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.3964887,-0.16685104,-1.6660742966508904,0.0012187233762596826
23916,SIDM00881,GSK269962A,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,49.0,3.827865,0.12731346,0.4564779081054537,0.0012187233762596826
70602,SIDM01136,Dasatinib,LGK974,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,85.0,-0.44885707,-0.036868103,-1.1566989249397186,-0.00450475859510669
48243,SIDM00866,Camptothecin,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.4524689,0.07277052,1.2304120646054184,-0.004153156025151664
69295,SIDM00498,BMS-754807,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Female,East Asian,77.0,-3.0977643,-0.10922897,-2.195768519747291,-0.004153156025151664
70695,SIDM00527,Linsitinib,Taselisib,Large Intestine,0.1,Colon Carcinoma,Unknown,Unknown,52.74992395704158,-1.3234677,-0.11628955,0.5204861862974228,0.0006292503840199699
31371,SIDM00885,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,41.0,3.1265485,0.0845372,1.7347445728743325,0.0012187233762596826
37560,SIDM00633,MK-2206,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.9512012,-0.13663894,-0.39341394769446514,-0.004153156025151664
75291,SIDM00833,LGK974,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Male,White,53.0,-1.0145372,-0.080419384,0.35356641528448696,-0.004153156025151664
54436,SIDM00216,Navitoclax,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.9450977,-0.07407736,0.2604465128670288,-0.00450475859510669
5771,SIDM00954,MK-2206,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,1.3519008,0.02662609,1.9278748099423497,0.0012187233762596826
5714,SIDM01233,Nutlin-3a (-),Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-3.3327734,-0.1078755,-1.4287135551004444,-0.004153156025151664
11090,SIDM00957,Trametinib,SB505124,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,0.8602691,0.066723384,0.40342961177349274,-0.00450475859510669
21875,SIDM00884,Alisertib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,43.0,3.5858147,0.14532119,0.2863006158498145,0.0012187233762596826
57984,SIDM01186,Entinostat,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,3.6502392,0.30020428,0.10946631119099634,0.0012187233762596826
66249,SIDM00885,Wee1 Inhibitor,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,41.0,-1.7414827,-0.14876811,-1.2761196361466092,-0.00450475859510669
82100,SIDM01137,Palbociclib,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,70.0,-2.1193404,-0.12655851,-0.8718393720430826,0.0008671208063046559
5316,SIDM00629,NU7441,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,43.0,-1.0296528,-0.0675459,0.312444157469372,0.0012187233762596826
36262,SIDM00779,Nutlin-3a (-),Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-2.458845,-0.09989899,-1.2482954155942554,0.0012187233762596826
92768,SIDM00633,Axitinib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.7706629,-0.048645012,-0.9326181074455662,-0.00450475859510669
53319,SIDM00562,Crizotinib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,46.0,1.7395838,0.08757636,2.4614745509297955,0.0049064349277283875
101662,SIDM00774,Alpelisib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.7672299,0.019104747,0.934071435982431,0.0008671208063046559
48973,SIDM00872,Navitoclax,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1728326,-0.027383178,0.32109476790195807,0.0012187233762596826
83409,SIDM00971,Lapatinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.770094,0.17047802,-1.032919451335004,0.0049064349277283875
33414,SIDM00872,Bortezomib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.48516384,-0.029164268,-0.877005613468845,-0.004153156025151664
37658,SIDM00885,BI-2536,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,41.0,-0.6833267,-0.082478136,-0.8759796689055173,-0.004153156025151664
22093,SIDM00879,AZD8055,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,32.0,3.5815682,0.13321324,0.35597778356030574,-0.0004654444736829603
31294,SIDM00314,Nilotinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,0.5983465,0.028154396,-0.314262343622863,0.0049064349277283875
55777,SIDM00928,Afatinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-1.4767282,-0.063055634,-0.027400493029115347,0.0012187233762596826
77408,SIDM00241,Camptothecin,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,East Asian,53.0,1.9444878,0.12560529,0.03838509002021171,0.0008671208063046559
24569,SIDM00878,Alisertib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.7231032,-0.06759958,0.01660009854880506,-0.004153156025151664
49341,SIDM00835,Nutlin-3a (-),Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-1.5221952,-0.13969664,-0.6037443750522512,-0.004153156025151664
74179,SIDM00282,Oxaliplatin,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,55.0,-0.48364717,-0.04137951,-0.3392024261758916,-0.004153156025151664
41485,SIDM00534,SCH772984,Camptothecin,Large Intestine,0.025,Colon Carcinoma,Unknown,Unknown,52.74992395704158,3.4051514,0.22124572,2.5870779951631606,0.0049064349277283875
21308,SIDM00193,Crizotinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,-2.938908,-0.13928649,0.7824221935828334,-0.0006810030359088663
19783,SIDM01062,OSI-027,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,50.0,1.1537865,0.046354413,-0.022332722251213615,-0.004153156025151664
81063,SIDM01090,Olaparib,Dabrafenib,Large Intestine,10.0,Colon Carcinoma,Unknown,Unknown,52.74992395704158,-0.18296035,-0.010545674,0.034846687755997224,-0.004153156025151664
48786,SIDM00933,SCH772984,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,2.7907698,0.07952277,0.295924117719195,0.0049064349277283875
58385,SIDM00898,Gemcitabine,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,43.0,-0.76263195,-0.016015137,0.12579317952289015,0.0008671208063046559
71167,SIDM00837,AZD8055,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,0.3383571,0.01921331,0.16928748377551628,-0.004153156025151664
38789,SIDM00571,LGK974,Taselisib,Pancreas,2.0,Pancreatic Adenosquamous Carcinoma,Male,East Asian,75.0,-4.661441,-0.16174355,-1.4779127976907345,-0.0006810030359088663
105524,SIDM00630,Ribociclib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,38.0,-0.9542441,-0.022909641,-1.1105019458988556,0.0012187233762596826
31296,SIDM01136,SCH772984,AZD7762,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,85.0,0.11585164,0.0017553921,0.32657005247912735,0.0012187233762596826
15426,SIDM00562,RO-3306,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,46.0,-0.898821,-0.079953834,-0.5154307119745528,0.0006292503840199699
102541,SIDM00928,Crizotinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,1.8047864,0.044282608,0.6313951075697517,0.0008671208063046559
50423,SIDM00146,Sorafenib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.1111413,-0.006558998,-0.9460713175467973,0.0012187233762596826
104855,SIDM00834,Olaparib,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,0.9693629,0.086875774,-0.049723083624826706,-0.004153156025151664
91013,SIDM00633,Dabrafenib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.5412092,0.21023056,1.2240445777737061,0.0012187233762596826
38712,SIDM00122,Entinostat,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,72.0,2.1245182,0.15266362,-2.4117573232299065,-0.004153156025151664
47957,SIDM00680,BMS-754807,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,58.0,2.1868331,0.25067407,1.1603247069787108,0.006001129785431316
40485,SIDM00898,Wee1 Inhibitor,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,43.0,0.2545363,0.010156146,1.0724865309633844,0.0249215129143481
26562,SIDM00282,Navitoclax,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,-0.10500851,-0.009799164,0.5283692482623171,-0.004153156025151664
49835,SIDM00954,Camptothecin,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.9426737,0.05476911,-0.27149771723045013,0.0012187233762596826
15375,SIDM00874,Axitinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,23.0,1.2837949,0.09887602,1.815270515891968,0.02082694692184988
25255,SIDM01042,Venetoclax,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7424164,-0.053140845,-1.1407239637276934,-0.004153156025151664
58187,SIDM00681,Olaparib,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,54.0,-1.2453343,-0.054752056,-0.5211664163398555,-0.004153156025151664
52277,SIDM00675,Afatinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,50.0,3.7408292,0.18599536,-0.41110817348134204,0.0012187233762596826
17777,SIDM00582,Ruxolitinib,SCH772984,Pancreas,1.0,Pancreatic Carcinoma,Female,East Asian,65.0,-2.2748668,-0.09236761,-0.9421486003338093,0.0012187233762596826
1784,SIDM00789,BMS-754807,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,52.74992395704158,0.824321,0.07001309,0.37678336885305685,-0.004153156025151664
21170,SIDM00583,OSI-027,AZD7762,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,56.0,-0.34186766,-0.015918985,1.7210414204924778,0.0249215129143481
92589,SIDM00628,Lapatinib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.9419458,0.14047775,-0.7001647796221083,0.0012187233762596826
35036,SIDM00673,Paclitaxel,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.4494889,-0.13647237,-0.3474463885406208,-0.004153156025151664
77043,SIDM00879,Navitoclax,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,32.0,1.7930244,0.113098845,1.5159299972087361,0.0008671208063046559
26825,SIDM01056,5-Fluorouracil,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,50.0,-1.5096955,-0.07045695,-1.1201382560906694,-0.004153156025151664
32756,SIDM00680,Crizotinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,58.0,-1.3570518,-0.036563583,1.206449268738089,0.0012187233762596826
89154,SIDM00469,AZD7762,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,Unknown,52.74992395704158,1.77316,0.07912997,1.432743112043854,0.0012187233762596826
83925,SIDM00135,Taselisib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.630708,0.10789251,1.163796408200671,-0.0004654444736829603
10566,SIDM00130,Taselisib,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.365199,-0.026983608,0.6469628846665958,0.0012187233762596826
34333,SIDM00842,SCH772984,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,55.0,2.736975,0.09034376,-0.02487348220711786,0.0008671208063046559
66727,SIDM01002,Lapatinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,White,46.0,-0.60561866,-0.01567888,0.24049569065299525,0.0008671208063046559
6697,SIDM00675,Pictilisib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,50.0,0.5928399,0.055128325,1.8403078744847048,0.02082694692184988
32526,SIDM00812,Navitoclax,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,53.0,-1.8112931,-0.090306476,-0.29050837757468734,-0.004153156025151664
9671,SIDM00938,Venetoclax,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,58.0,0.39873043,0.033411603,-0.894695234919264,-0.00450475859510669
72132,SIDM00097,Sorafenib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3079789,-0.09027337,-0.9191097811255184,0.0008671208063046559
64588,SIDM00774,Camptothecin,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-3.8531497,-0.067565605,-0.9654007058136659,0.0012187233762596826
60040,SIDM00097,Nutlin-3a (-),Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.68563575,-0.06788956,0.021915414986524186,-0.004153156025151664
16935,SIDM00314,Vorinostat,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,1.548902,0.10152943,0.8605711182179091,0.0012187233762596826
44520,SIDM00881,Tozasertib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,49.0,1.4199923,0.14400725,-0.4893497410630637,0.0012187233762596826
22190,SIDM00571,Ruxolitinib,LGK974,Pancreas,2.5,Pancreatic Adenosquamous Carcinoma,Male,East Asian,75.0,-0.2834683,-0.015737548,-0.3786198200871176,-0.0010326056058638932
83236,SIDM00933,5-Fluorouracil,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.34120315,0.029101137,-0.026968639785977744,-0.0006810030359088663
36114,SIDM00132,5-Fluorouracil,MK-2206,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Female,Unknown,61.0,-1.1970296,-0.10896077,0.2935087658829547,-0.004153156025151664
21523,SIDM00783,Navitoclax,Taselisib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,52.74992395704158,-1.2527863,-0.07954021,-0.5606382102533981,-0.00450475859510669
71935,SIDM00487,AZD4547,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,Unknown,52.74992395704158,0.90240234,0.043353524,-0.3155126944603493,0.0012187233762596826
39241,SIDM01186,SCH772984,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,-0.032834068,-0.0024557123,-0.10554367570826312,-0.004153156025151664
30632,SIDM00193,5-Fluorouracil,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,-1.0444142,-0.025852492,0.6711360636192515,0.0008671208063046559
65653,SIDM00892,Sorafenib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,23.0,-2.3370702,-0.18615733,-1.0421696519182486,-0.004153156025151664
71005,SIDM00885,Dabrafenib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,41.0,-0.25338343,-0.03229484,-0.5356167155438514,-0.004153156025151664
59072,SIDM00872,MK-1775,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-3.0075269,-0.15227982,-0.480063655612651,0.0012187233762596826
79189,SIDM00582,Cisplatin,Erlotinib,Pancreas,2.5,Pancreatic Carcinoma,Female,East Asian,65.0,1.5133502,0.057684675,1.4894083063049484,0.0012187233762596826
26061,SIDM00782,MK-1775,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,Unknown,72.0,-1.5148882,-0.0675047,1.2476559182038292,0.0012187233762596826
31041,SIDM01188,Dasatinib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,White,57.0,0.34823725,0.011824888,0.34804028637827045,-0.0004654444736829603
33806,SIDM01056,OSI-027,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,50.0,0.6937519,0.020382829,0.7510913658111505,0.0049064349277283875
78769,SIDM00877,Camptothecin,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,-5.4727817,-0.012895547,-0.11782541363340808,-0.004153156025151664
91714,SIDM01090,Trametinib,AZD8055,Large Intestine,0.125,Colon Carcinoma,Unknown,Unknown,52.74992395704158,3.361794,0.26430303,2.748594568668279,-0.0004654444736829603
37079,SIDM00928,Docetaxel,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,-0.642164,-0.025066644,-0.1993478655188869,-0.004153156025151664
50202,SIDM00933,Palbociclib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-1.2749224,-0.0767676,-0.9303785973541165,-0.0004654444736829603
61971,SIDM01056,MK-2206,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,50.0,2.7180424,0.003422313,0.04571775502407428,-0.004153156025151664
21824,SIDM00528,Crizotinib,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,40.0,-2.318241,-0.099680275,-0.9567714994225096,0.0012187233762596826
53904,SIDM00812,Nutlin-3a (-),Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,53.0,-1.5689882,-0.09391086,2.238046398599573,0.02082694692184988
8881,SIDM00216,SB505124,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,2.1826892,0.10893309,1.9085668919521197,0.0012187233762596826
28285,SIDM00541,LGK974,SB505124,Large Intestine,0.625,Colon Carcinoma,Unknown,Unknown,52.74992395704158,2.9397168,0.16929777,-0.11457178557403291,0.0012187233762596826
31749,SIDM00782,Dabrafenib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,3.3542123,0.19079761,0.5614474094574339,-0.004153156025151664
49641,SIDM00214,LGK974,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,37.0,-2.2646563,-0.055817835,-1.2719247699671272,0.0008671208063046559
94542,SIDM00832,Trametinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-2.059375,-0.2128965,-0.3145663242575415,-0.004153156025151664
83164,SIDM00938,Doramapimod,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,58.0,1.953689,0.046484683,0.4121944457373616,0.02082694692184988
77808,SIDM00878,JQ1,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,0.24611232,0.018698277,0.6600934312772144,-0.00450475859510669
98235,SIDM00541,MK-1775,Dabrafenib,Large Intestine,10.0,Colon Carcinoma,Unknown,Unknown,52.74992395704158,0.69098175,0.021276228,0.06549673262509023,-0.0004654444736829603
21245,SIDM00097,Doramapimod,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2039642,-0.033877343,-0.7206255127809154,-0.004153156025151664
61899,SIDM00628,Linsitinib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.4237586,-0.03826474,-1.239500206173102,-0.004153156025151664
76820,SIDM01135,Taselisib,Palbociclib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,52.74992395704158,3.8074682,0.12990919,-1.0126738547202938,-0.004153156025151664
7079,SIDM00898,Vorinostat,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,43.0,2.1356444,0.21455455,-0.39817587910343444,0.0008671208063046559
19870,SIDM00884,KU-55933,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,43.0,-2.3033118,-0.06964053,-1.2273887043175318,0.0012187233762596826
71854,SIDM00879,Alpelisib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,32.0,-0.4107237,-0.041296303,-0.5327839339037312,-0.00450475859510669
68566,SIDM00971,Nutlin-3a (-),Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.3851597,0.2825915,0.5035461886533265,-0.004153156025151664
73448,SIDM00660,AZD4547,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,-0.23542832,-0.020376764,0.6972189088995407,-0.0004654444736829603
67517,SIDM00583,Gemcitabine,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,56.0,5.364633,0.43759605,0.36653407934269605,0.0012187233762596826
59332,SIDM00879,AZD8055,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,32.0,0.3294093,0.012183615,0.4678528753227312,-0.004153156025151664
37478,SIDM00301,Sorafenib,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.8456769,-0.08768334,-0.6744913865892892,-0.004153156025151664
90985,SIDM00832,MK-1775,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.5975736,-0.10019063,-1.0502961228065302,0.0008671208063046559
24776,SIDM00628,Entinostat,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-1.568911,-0.15399313,-0.11377672404865043,-0.004153156025151664
51498,SIDM01062,Venetoclax,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,50.0,-1.3469504,-0.046363134,-0.5577453721031977,-0.004153156025151664
38881,SIDM01056,Vorinostat,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,50.0,2.1994016,0.10488339,1.4110527058328377,0.0008671208063046559
55837,SIDM00455,5-Fluorouracil,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.7111292,-0.09393538,-0.48911751961238875,-0.004153156025151664
14196,SIDM00529,Doramapimod,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,-4.294716,-0.23228562,-1.310792331267702,-0.00450475859510669
101822,SIDM00933,Nilotinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-1.5847561,-0.07812577,-1.7360933153562104,-0.004153156025151664
29033,SIDM00150,AZD8055,Dabrafenib,Large Intestine,1.0,Colon Carcinoma,Unknown,Unknown,52.74992395704158,-0.6395905,-0.048363995,0.05515545003195777,-0.00450475859510669
5931,SIDM00874,NU7441,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,23.0,0.90463746,0.08444421,-0.03163143497766003,-0.00450475859510669
62319,SIDM00898,AZD7762,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,43.0,1.2133143,0.0804909,-1.0133680576315036,-0.004153156025151664
7741,SIDM01137,Palbociclib,MK-2206,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,70.0,0.6168848,0.056248516,0.8550333156157854,-0.0004654444736829603
23329,SIDM01137,Dasatinib,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,70.0,0.9751521,0.03300116,-0.7415480110212929,-0.004153156025151664
25372,SIDM00774,MK-2206,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.3791685,-0.10397325,-0.5432855691225512,-0.00450475859510669
29086,SIDM00214,LGK974,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,37.0,1.3572578,0.077470385,0.4700002322400459,0.0012187233762596826
93871,SIDM01187,Docetaxel,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.65472096,0.058585368,-0.20363058237086862,-0.004153156025151664
76295,SIDM00934,Olaparib,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,40.0,-2.3637893,-0.084949516,0.5973760783765797,0.0008671208063046559
34995,SIDM00314,MK-2206,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,2.1304417,0.07816848,-0.1504249032792865,-0.004153156025151664
86986,SIDM01139,Erlotinib,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,White,70.0,-0.88595915,-0.058833998,-0.8114138781831582,-0.00450475859510669
67647,SIDM00872,NU7441,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,3.2734702,0.11657345,1.2198880086835864,0.0012187233762596826
100452,SIDM01186,Uprosertib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,-1.4290787,-0.11844831,-0.9586414360289394,-0.00450475859510669
80973,SIDM00217,5-Fluorouracil,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,34.0,1.3841928,0.036911085,0.8414684656047646,0.0008671208063046559
62068,SIDM00928,Tozasertib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,0.62372005,0.031846568,0.9880298302251286,0.0012187233762596826
53428,SIDM00877,Trametinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.3093512,-0.087296315,-0.057268299773339394,-0.004153156025151664
10498,SIDM00673,Uprosertib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,3.1665287,0.2311891,-0.8838385900651203,0.0012187233762596826
95263,SIDM00778,BMS-754807,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,5.192626,0.07432438,2.627776345025054,0.023983142683845143
88885,SIDM00954,Gemcitabine,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-5.218447,-0.29329666,-2.887812934253562,-0.004153156025151664
93113,SIDM00879,Ribociclib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,32.0,0.76025826,0.05752883,0.5925191543322604,-0.004153156025151664
55717,SIDM00135,Nutlin-3a (-),Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.642738,0.021055354,2.287445801980283,0.0249215129143481
12924,SIDM01037,AZD7762,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,62.0,-0.22398587,-0.018441405,-0.775503382674728,-0.00450475859510669
51664,SIDM00899,Paclitaxel,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Female,White,62.0,2.3661118,0.36406022,0.9185194357185696,0.0049064349277283875
54196,SIDM00664,Paclitaxel,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,White,46.0,-1.8067663,-0.16387783,-0.6636732121384358,-0.004153156025151664
16763,SIDM01137,Palbociclib,Olaparib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,70.0,1.6702603,0.064808674,-0.7316461124591763,0.0012187233762596826
108140,SIDM01136,Palbociclib,AZD7762,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,85.0,0.6286491,0.024160286,0.21274706310327066,-0.004153156025151664
22562,SIDM00877,Navitoclax,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.7388445,0.06889873,1.5147567228211387,0.0012187233762596826
89388,SIDM00881,Olaparib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,49.0,6.7690663,0.52700984,1.3360447008598548,0.0012187233762596826
92022,SIDM00882,Entinostat,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Other,42.0,-1.3820384,-0.03723464,0.48499123193876464,0.0012187233762596826
93174,SIDM00933,RO-3306,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.25939232,0.0046778945,-0.21876023461747926,-0.0004654444736829603
53252,SIDM01137,5-Fluorouracil,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,70.0,-2.5516405,-0.08808375,-1.9350415684334952,0.0012187233762596826
64665,SIDM00841,LGK974,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,51.0,-1.2979252,-0.08504851,-0.3329831039252017,-0.004153156025151664
15680,SIDM00675,Paclitaxel,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,50.0,0.37243447,0.03718422,0.04730888260937941,-0.004153156025151664
93801,SIDM00933,Nutlin-3a (-),OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,3.949923,0.15765904,-0.007531221268595462,0.0012187233762596826
25120,SIDM00118,Linsitinib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.2659833,0.114764065,0.10266323192007544,0.0049064349277283875
39967,SIDM01002,Ribociclib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,White,46.0,-0.8956591,-0.085243724,-0.6525909711373307,-0.004153156025151664
51055,SIDM00146,Tozasertib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-2.696445,-0.10266015,-1.5911900868718478,0.0012187233762596826
106866,SIDM00534,Vinorelbine,Nutlin-3a (-),Large Intestine,10.0,Colon Carcinoma,Unknown,Unknown,52.74992395704158,-0.69632787,-0.026361233,0.7204338511283579,0.0012187233762596826
29750,SIDM00527,Crizotinib,Taselisib,Large Intestine,0.1,Colon Carcinoma,Unknown,Unknown,52.74992395704158,1.4721302,0.025143133,2.763855183769265,0.0012187233762596826
107768,SIDM00582,Taselisib,Olaparib,Pancreas,2.5,Pancreatic Carcinoma,Female,East Asian,65.0,-2.5457926,-0.19652985,-0.4221725598641683,-0.004153156025151664
40128,SIDM00963,PF-4708671,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,60.0,4.4147573,0.094470836,1.9552709892720064,0.007858728252343744
87423,SIDM01090,AZD8055,AZD4547,Large Intestine,2.5,Colon Carcinoma,Unknown,Unknown,52.74992395704158,-1.2902696,-0.04710442,-0.363964849454476,0.0008671208063046559
65847,SIDM00882,Trametinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Other,42.0,-1.9010754,-0.08517618,-0.9940885880233754,0.0012187233762596826
23475,SIDM00314,Uprosertib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,-0.7153461,-0.05884505,0.12209886508333803,-0.004153156025151664
37271,SIDM01001,Docetaxel,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,62.0,3.5256984,0.36194956,1.0934110424816104,0.0012187233762596826
42213,SIDM00940,SCH772984,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,43.0,-0.83487135,-0.018234532,0.4015604824410438,0.0012187233762596826
106946,SIDM00301,Sorafenib,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.27465022,-0.015795145,-0.09160814839194659,-0.004153156025151664
67706,SIDM00877,PF-4708671,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-0.6206322,-0.055680856,-0.2602712290886026,-0.0004654444736829603
9923,SIDM00528,Ribociclib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,40.0,-2.8527646,-0.062233604,-1.4224184965272564,0.0012187233762596826
39826,SIDM01136,MK-1775,Linsitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,85.0,0.56852555,0.030874673,-1.3578372101590723,-0.004153156025151664
12537,SIDM01188,Sorafenib,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,White,57.0,-1.7860206,-0.1326124,-0.7855517673994635,-0.00450475859510669
10354,SIDM00150,Taselisib,Vinorelbine,Large Intestine,0.01,Colon Carcinoma,Unknown,Unknown,52.74992395704158,0.5984382,0.042854536,0.5811464790873941,0.0012187233762596826
51926,SIDM01138,SCH772984,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,White,65.0,-0.65384597,-0.034699757,-0.5856317287780735,0.0012187233762596826
3608,SIDM00216,Vinorelbine,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.5351323,0.068738215,0.3726338140771336,0.0012187233762596826
48534,SIDM00826,Nutlin-3a (-),Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,70.0,-1.7129568,-0.089653976,-0.892403416301997,-0.004153156025151664
87711,SIDM00899,Linsitinib,MK-2206,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Female,White,62.0,2.8660455,0.30036077,1.4328840351052246,0.0012187233762596826
33691,SIDM00049,Crizotinib,AZD8055,Large Intestine,0.125,Colorectal Carcinoma,Female,Unknown,46.0,1.2180895,0.0340679,3.1698613123871295,0.0012187233762596826
58212,SIDM00049,Camptothecin,Taselisib,Large Intestine,0.1,Colorectal Carcinoma,Female,Unknown,46.0,-1.869924,-0.097328275,-1.2655394791939214,0.0008671208063046559
2733,SIDM00527,MK-2206,BMS-754807,Large Intestine,0.05,Colon Carcinoma,Unknown,Unknown,52.74992395704158,4.1174364,0.068216816,1.978674088233322,0.0012187233762596826
98538,SIDM00885,Nilotinib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,41.0,2.8963912,0.21030737,-1.9447577617233986,0.0008671208063046559
74772,SIDM00940,Bortezomib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,43.0,-1.6262127,-0.06345206,-0.26967794074321627,0.0012187233762596826
86773,SIDM00772,ZM447439,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,38.0,5.9717813,0.15325287,1.2659881888817492,0.0012187233762596826
94748,SIDM00455,Crizotinib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.1296427,-0.12553258,-0.3405619472588581,-0.004153156025151664
42548,SIDM00774,PF-4708671,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,0.7430411,0.041048527,-0.3895475372313441,-0.0004654444736829603
1806,SIDM00122,OSI-027,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,72.0,0.6493147,0.018986939,0.5986726747366592,-0.004153156025151664
75536,SIDM01002,Pictilisib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,White,46.0,1.0659628,0.09962039,1.268930745010683,0.0012187233762596826
53293,SIDM00875,JQ1,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.85691166,0.030176774,-1.0147795609441703,0.0012187233762596826
84725,SIDM00971,Bortezomib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.6874833,-0.13245767,-0.7885799068155582,-0.004153156025151664
51767,SIDM00940,Crizotinib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,43.0,4.7015233,0.41848707,1.091295423747865,0.0012187233762596826
32379,SIDM00881,Entinostat,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,49.0,-1.8713975,-0.077440806,0.421483906241994,-0.004153156025151664
61264,SIDM00772,Pictilisib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,38.0,5.38656,0.16513714,0.7877666752931515,0.0012187233762596826
77126,SIDM00944,Crizotinib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,52.74992395704158,-0.67385256,-0.06380588,-2.486784760495997,-0.00450475859510669
74043,SIDM00885,Linsitinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,41.0,-1.551066,-0.05248644,0.30988873159541996,0.0008671208063046559
35415,SIDM00971,PD173074,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.8270486,0.02500827,1.0910682830222178,0.0008671208063046559
53265,SIDM00118,Oxaliplatin,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.6390423,-0.04135251,0.20415595950163104,-0.00450475859510669
83131,SIDM01002,AZD8055,Lapatinib,Breast,0.625,Breast Carcinoma,Female,White,46.0,1.1249332,0.05350386,-0.26743612582721926,0.0049064349277283875
41176,SIDM01056,NU7441,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,50.0,2.1819904,0.11454641,0.9637520156044153,-0.004153156025151664
21809,SIDM00812,Camptothecin,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,53.0,1.0364299,0.09620991,0.11065614406500941,-0.004153156025151664
13685,SIDM00892,Ribociclib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,23.0,2.7562613,0.097675405,0.39384917196120584,0.0006292503840199699
37061,SIDM00781,Trametinib,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Female,East Asian,43.0,-0.49031252,-0.018798212,0.2738687425610056,-0.004153156025151664
65908,SIDM01186,Gemcitabine,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,1.2239095,0.09024959,-1.3389415888468017,0.0008671208063046559
8869,SIDM00866,5-Fluorouracil,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-2.1807077,-0.054777596,0.10372602654650713,0.0008671208063046559
60581,SIDM00872,BI-2536,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.8999423,-0.2640702,0.20909067140039644,-0.00450475859510669
79417,SIDM00332,MK-1775,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3766348,0.103261046,-0.4568659797629505,-0.00450475859510669
87343,SIDM00875,Linsitinib,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7273311,0.05958521,-0.615311248463247,-0.004153156025151664
78516,SIDM00631,Sorafenib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,White,43.0,2.7606428,0.16774294,1.5198592145781544,0.0249215129143481
33530,SIDM01001,Vorinostat,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,62.0,1.0371995,0.06310725,1.1904582430498154,0.009831670697094548
83773,SIDM00899,Irinotecan,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Female,White,62.0,-1.4037771,-0.090634584,-0.525328746403794,-0.0010326056058638932
98139,SIDM01001,Crizotinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,62.0,3.3916802,0.18797636,-1.2541285845740753,-0.0010326056058638932
32380,SIDM00272,Pictilisib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,48.0,3.4662821,0.1523864,2.1439106217622896,0.006001129785431316
89275,SIDM01090,Olaparib,SCH772984,Large Intestine,0.5,Colon Carcinoma,Unknown,Unknown,52.74992395704158,6.721842,0.4255697,1.3224296752927245,0.0049064349277283875
82534,SIDM00631,Gemcitabine,Cisplatin,Breast,1.0,Breast Carcinoma,Female,White,43.0,-1.2298795,-0.04748138,-0.626837517459606,0.0008671208063046559
30035,SIDM00881,Linsitinib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,49.0,-4.0751657,-0.18927419,-0.9236868555690194,-0.004153156025151664
94530,SIDM00148,Gemcitabine,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.0986962,0.22342399,2.596950956293013,0.0249215129143481
61851,SIDM00833,Oxaliplatin,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Male,White,53.0,-1.0953801,-0.09818507,0.05521415475529357,-0.004153156025151664
18792,SIDM00541,Olaparib,Navitoclax,Large Intestine,0.1,Colon Carcinoma,Unknown,Unknown,52.74992395704158,-1.015919,-0.106530204,-0.9934173829929656,-0.00450475859510669
23487,SIDM00878,Paclitaxel,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.9283756,-0.06616697,-0.8436042227913365,0.0012187233762596826
6659,SIDM00875,Docetaxel,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.9154273,-0.07792722,0.8137023954269,-0.0004654444736829603
93238,SIDM01197,Oxaliplatin,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.6512008,-0.09233163,-0.8502177676246048,0.0012187233762596826
8966,SIDM00488,LGK974,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,Unknown,52.74992395704158,-1.0426203,-0.018429073,1.1110557434704649,0.0012187233762596826
61959,SIDM00453,Crizotinib,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,64.0,-0.936419,-0.09532889,-1.3289119870949566,-0.004153156025151664
43153,SIDM00122,Wee1 Inhibitor,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,72.0,1.0609035,0.035491847,1.30746837976064,0.0012187233762596826
83539,SIDM00866,Olaparib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-2.3806086,-0.082777515,3.028364501291241,0.0249215129143481
48474,SIDM01186,BI-2536,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,-0.75962335,-0.0369521,-1.6087265512071862,0.0008671208063046559
95636,SIDM00629,Lapatinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,43.0,2.06041,0.11023338,0.40270748266024536,0.0008671208063046559
102818,SIDM00878,Entinostat,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,5.2023706,0.26399663,0.967696255955345,0.0249215129143481
84391,SIDM00528,Vorinostat,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,40.0,-1.8315164,-0.064022474,0.4395991951052571,0.0049064349277283875
42678,SIDM00892,RO-3306,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,23.0,-1.012881,-0.10281673,0.06657870898153619,-0.004153156025151664
102166,SIDM00411,Ruxolitinib,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-0.9232275,-0.05428252,-0.16468032685074227,-0.004153156025151664
85583,SIDM01037,MK-1775,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,62.0,1.4259742,0.04269767,0.563324001197896,0.0012187233762596826
20541,SIDM00878,Pictilisib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.80089253,-0.0184492,1.4010174643018791,0.0012187233762596826
55182,SIDM00533,Olaparib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,66.0,1.5106024,0.16353819,-0.12260402939963488,-0.004153156025151664
26757,SIDM00875,Nilotinib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.4634909,0.03741985,0.6920349575353018,-0.004153156025151664
73349,SIDM00042,Taselisib,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.62326616,-0.046071887,-0.4515328779725077,-0.00450475859510669
51706,SIDM01042,Pictilisib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3026184,0.120012335,0.3506731481123939,-0.004153156025151664
7837,SIDM00571,Erlotinib,MK-1775,Pancreas,2.0,Pancreatic Adenosquamous Carcinoma,Male,East Asian,75.0,2.6194024,0.10998822,0.9731140845942756,0.0049064349277283875
32158,SIDM00282,LGK974,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,-0.50475293,-0.032924898,-0.1346512278466586,-0.004153156025151664
66267,SIDM01037,Axitinib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,62.0,-0.9480444,-0.039942123,-0.2729527578490245,-0.00450475859510669
89069,SIDM01096,MK-1775,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,65.0,-2.0814779,-0.18869436,-2.3407824056138193,-0.00450475859510669
75849,SIDM00839,Oxaliplatin,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,56.0,-0.90774214,-0.052743398,0.6321992823132916,0.0008671208063046559
95733,SIDM00193,MK-2206,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,-0.3225188,-0.045968276,-0.007170643490389805,-0.004153156025151664
68333,SIDM00135,Afatinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.5353941,0.033454534,-0.0036798019223752646,-0.004153156025151664
85721,SIDM00214,Camptothecin,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,37.0,1.2385842,0.031108212,-0.11106220535021466,0.0012187233762596826
44751,SIDM01187,Nutlin-3a (-),Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.90375525,-0.085676186,0.256571493187,-0.00450475859510669
83399,SIDM00874,Alpelisib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,23.0,-0.8342753,-0.073282294,-0.638180859437987,-0.00450475859510669
3398,SIDM00872,Olaparib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,2.853303,0.14365184,-0.1173969574266949,0.0012187233762596826
71731,SIDM00216,SB505124,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.52008337,-0.06683552,-0.6918664910926503,-0.004153156025151664
49074,SIDM00148,5-Fluorouracil,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.38830402,0.040727604,0.6336457713528123,-0.00450475859510669
54557,SIDM00971,AZD6482,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.234259,0.07367582,-1.9381449224805982,0.0008671208063046559
50034,SIDM00469,LGK974,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,Unknown,52.74992395704158,-3.3626828,-0.16459401,-1.2885855227425251,0.0012187233762596826
31690,SIDM00899,MK-2206,Olaparib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Female,White,62.0,-0.1390402,-0.010499338,0.24381104183832988,-0.004153156025151664
100231,SIDM00875,JQ1,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5052773,0.13835198,0.8729857588180325,0.0012187233762596826
98472,SIDM00777,Taselisib,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,55.0,0.71606076,0.017987106,0.19068317833687992,0.0012187233762596826
61069,SIDM00933,Venetoclax,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-1.553109,-0.07302307,-0.8018518846225794,-0.004153156025151664
11578,SIDM00892,Alpelisib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,23.0,-0.3503776,-0.01794014,-0.637852336069964,-0.004153156025151664
81808,SIDM00505,Lapatinib,Dasatinib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,65.0,-2.2872934,-0.09974773,-1.5213308650180348,0.0012187233762596826
79211,SIDM00893,RO-3306,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.14440602,0.002942712,2.0390360521713493,0.0012187233762596826
51419,SIDM00776,AZD8055,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-1.3570122,-0.10712862,-0.07446355882529972,-0.004153156025151664
90744,SIDM00779,Olaparib,Afatinib,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,-0.79675555,-0.06745563,-0.328784250591981,-0.004153156025151664
11119,SIDM00954,Luminespib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.6207878,-0.06021485,0.2894582430716979,-0.00450475859510669
35620,SIDM01002,ZM447439,Crizotinib,Breast,0.625,Breast Carcinoma,Female,White,46.0,1.0162832,0.058613837,0.15845461905302952,0.0008671208063046559
101780,SIDM00453,5-Fluorouracil,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,64.0,-1.2356578,-0.08698306,-0.3113058367107819,0.0008671208063046559
62422,SIDM00217,Navitoclax,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,34.0,-1.0325098,-0.0896278,-0.3191797461078796,-0.00450475859510669
46452,SIDM00314,MK-1775,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,0.9961327,0.03532275,0.2987701326989686,0.0012187233762596826
74578,SIDM00899,Erlotinib,Palbociclib,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Female,White,62.0,-0.44646508,-0.020536842,-0.16863226409775536,-0.004153156025151664
101025,SIDM01186,Dabrafenib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,4.147702,0.13659383,2.130535302392419,0.006001129785431316
83051,SIDM00301,Lapatinib,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.42512864,-0.04190801,-1.1816344180844849,-0.00450475859510669
92206,SIDM00148,Palbociclib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0601597,-0.10386511,-1.971076990925711,-0.00450475859510669
90083,SIDM00839,MK-2206,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,56.0,1.9312196,0.046502903,2.0132641684758674,-0.004153156025151664
12593,SIDM00893,NU7441,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.5118606,-0.074215,-1.7457076060309018,0.0008671208063046559
49344,SIDM00498,MK-1775,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Female,East Asian,77.0,1.0564551,0.019670378,2.0400017261903445,0.0012187233762596826
58803,SIDM00453,Navitoclax,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,64.0,2.4324098,0.11320057,0.7910300227136253,0.0012187233762596826
66422,SIDM00877,Crizotinib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.4406072,-0.054511227,-0.3947550864824771,0.0008671208063046559
81954,SIDM01001,BI-2536,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,62.0,-1.2781029,-0.090717964,-1.4701639178161077,0.0012187233762596826
20330,SIDM00122,AZD6482,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,72.0,1.7830323,0.09372422,-0.0637428192638527,0.0012187233762596826
47502,SIDM00629,PD173074,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,43.0,-1.6227342,-0.07425423,-1.34473418497085,-0.0010326056058638932
32800,SIDM00954,Dabrafenib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.42409554,0.010691202,1.511628868229663,0.006001129785431316
105674,SIDM00772,Afatinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,38.0,-0.6225513,-0.011742067,-1.399037364446665,-0.00450475859510669
79070,SIDM00583,MK-1775,OSI-027,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,56.0,-2.7846575,-0.08167083,-0.5590307594696927,0.0008671208063046559
29330,SIDM00940,Cisplatin,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,43.0,0.97635984,0.020635735,0.27494892150350797,0.0012187233762596826
49612,SIDM00774,Sorafenib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.3617414,-0.11161088,0.1951823196417194,-0.0006810030359088663
32245,SIDM00934,SCH772984,Palbociclib,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,40.0,0.8485421,0.08496278,0.6924905975593955,-0.004153156025151664
40315,SIDM00963,Camptothecin,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,60.0,-3.131648,-0.1245457,-1.7512271218059017,0.0012187233762596826
16817,SIDM00841,AZD8055,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,51.0,2.4228897,0.105152465,1.1431424361421283,0.0012187233762596826
65238,SIDM00680,MK-2206,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,58.0,-0.49913883,-0.037164122,-0.011739881077169882,-0.0006810030359088663
14408,SIDM00314,Entinostat,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,0.86776006,0.11066106,0.3616614253955052,-0.00450475859510669
87449,SIDM00531,Lapatinib,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.1052077,0.03374126,1.488582343453026,0.0006292503840199699
82403,SIDM00241,OSI-027,MK-2206,Breast,1.0,Breast Carcinoma,Female,East Asian,53.0,-0.892273,-0.07951038,-0.5643553358665654,-0.00450475859510669
107694,SIDM00664,5-Fluorouracil,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,White,46.0,2.7009063,0.16759129,1.4979572452904588,0.0008671208063046559
74522,SIDM00631,MK-2206,Lapatinib,Breast,2.5,Breast Carcinoma,Female,White,43.0,-0.6938666,-0.07398311,-0.02256225541197365,-0.004153156025151664
66722,SIDM01165,Lapatinib,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,White,56.0,-2.0516744,-0.11494826,-0.5586039270030586,-0.004153156025151664
72657,SIDM00877,PD173074,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,0.85095257,0.022296589,0.5978996880347017,0.0012187233762596826
88930,SIDM00878,JQ1,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,0.7342266,0.07165077,-0.39655476810304846,-0.004153156025151664
103320,SIDM00879,NU7441,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,32.0,-1.0916042,-0.06118977,-1.7577175040384851,0.0012187233762596826
48970,SIDM00878,MK-2206,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,-4.982709,-0.14710648,-1.6254573234046379,-0.00450475859510669
57643,SIDM01062,ZM447439,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,50.0,-0.38321656,-0.01071083,0.5121991064345389,0.0008671208063046559
78431,SIDM00136,Taselisib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,44.0,-1.1544096,-0.030279126,0.08434971150358249,0.0012187233762596826
5823,SIDM00833,AZD4547,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.10061618,-0.007607849,-0.6674373421765796,-0.004153156025151664
2874,SIDM00527,AZD8055,Crizotinib,Large Intestine,2.5,Colon Carcinoma,Unknown,Unknown,52.74992395704158,0.92037445,0.09880597,-0.6364163936920042,-0.00450475859510669
52650,SIDM00314,Nilotinib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,1.339199,0.10970799,-0.14127239962121899,0.0006292503840199699
59017,SIDM00963,Trametinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,60.0,1.8200774,0.14032191,0.6990068692991831,-0.004153156025151664
98082,SIDM00314,PD173074,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,1.5069157,0.20960008,0.4366236219708192,-0.00450475859510669
84403,SIDM00881,JQ1,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,49.0,0.507427,0.034293827,-0.8999359562846729,-0.004153156025151664
42095,SIDM00899,Olaparib,AZD7762,Pancreas,0.0625,Pancreatic Ductal Adenocarcinoma,Female,White,62.0,-3.684592,-0.14869052,-0.7574270411926892,0.0008671208063046559
77044,SIDM00314,GSK269962A,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,-0.61513853,-0.06405587,-0.3559875848027675,-0.00450475859510669
55487,SIDM00920,Luminespib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-1.143019,-0.08776782,-1.0535438452304915,-0.0006810030359088663
5744,SIDM00042,Trametinib,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-2.2643416,-0.19046281,-1.1966948251195069,-0.00450475859510669
89873,SIDM00920,Sorafenib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.9972415,0.12996727,0.09605760656939769,0.0008671208063046559
83427,SIDM00777,Vinorelbine,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,55.0,-2.7397077,-0.16088822,-0.9990478519149295,-0.00450475859510669
90737,SIDM00866,JQ1,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,-0.47857508,-0.015248836,0.2737607638637089,0.0012187233762596826
53945,SIDM00528,Cisplatin,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,40.0,-3.6234157,-0.120821685,-0.19977494006607485,-0.004153156025151664
84758,SIDM00772,Entinostat,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,38.0,-1.353137,-0.061895035,-1.2700922998688986,0.0008671208063046559
61042,SIDM01186,Nilotinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,0.6311119,0.06145948,0.675387863412963,-0.0006810030359088663
14925,SIDM00097,Doramapimod,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.07059278,0.0010871828,-0.2970544866348792,0.0008671208063046559
46898,SIDM01096,Olaparib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,65.0,-0.6607177,-0.05119852,-1.3008838615141372,-0.00450475859510669
2487,SIDM00371,OSI-027,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,East Asian,73.0,-1.6975473,-0.08388719,0.4741962268817449,-0.004153156025151664
71695,SIDM00954,Gemcitabine,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,2.4176483,0.2850521,0.240602722647002,0.0049064349277283875
68031,SIDM00881,Linsitinib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,49.0,2.1638975,0.044922356,1.090102148585671,-0.004153156025151664
29797,SIDM00675,Alisertib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,50.0,-1.5771149,-0.031052476,0.48135885869055206,0.0049064349277283875
107769,SIDM00834,Oxaliplatin,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,White,66.0,1.4734055,0.027788496,2.2915779886873477,0.0249215129143481
45857,SIDM00675,Pictilisib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,50.0,-1.0993634,-0.077825,-1.5877713214404423,-0.00450475859510669
86303,SIDM00533,Sorafenib,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,66.0,1.0619379,0.036900237,0.7211713844216779,0.0012187233762596826
52729,SIDM00122,SCH772984,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,72.0,-1.221459,-0.06749555,-0.11997778464669043,-0.00450475859510669
67676,SIDM00214,Oxaliplatin,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,37.0,-0.14782172,-0.015204148,-0.5057284644743231,-0.0006810030359088663
18408,SIDM00938,Paclitaxel,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,58.0,1.0130447,0.06869171,-0.9115811671321296,0.0012187233762596826
15355,SIDM00332,Navitoclax,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6652376,0.05344037,0.2537353469734115,-0.004153156025151664
82029,SIDM00629,Venetoclax,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,43.0,0.84452647,0.07444152,-0.2923024781338059,-0.004153156025151664
77304,SIDM01096,Navitoclax,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,65.0,-0.39970833,-0.033098478,-0.6102878070348191,-0.00450475859510669
6395,SIDM00882,OSI-027,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Other,42.0,0.7961649,0.046509046,0.17962376295137658,-0.0004654444736829603
88391,SIDM00943,Navitoclax,OSI-027,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,56.0,-0.42211205,-0.020631677,-0.1696573769837482,0.0008671208063046559
88177,SIDM00469,AZD7762,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,Unknown,52.74992395704158,-1.5833775,-0.1571003,-1.1209214874264042,-0.004153156025151664
70403,SIDM01037,Uprosertib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,62.0,4.9629254,0.1639484,1.505863723992936,-0.004153156025151664
72788,SIDM00877,MK-1775,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.34497714,-0.010521852,-0.5058307382007924,0.0012187233762596826
67181,SIDM00920,Navitoclax,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.85429144,0.012559904,0.5923958352717672,0.0012187233762596826
81511,SIDM00680,5-Fluorouracil,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,58.0,0.91670036,0.019979082,1.2891961254885471,0.0012187233762596826
63296,SIDM00049,Olaparib,Afatinib,Large Intestine,1.0,Colorectal Carcinoma,Female,Unknown,46.0,-1.3222735,-0.09908354,-0.34589156613076966,-0.004153156025151664
42397,SIDM01037,Entinostat,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,62.0,2.9020646,0.1033218,0.2861783790511966,0.0012187233762596826
48554,SIDM01139,Olaparib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,White,70.0,2.5141575,0.18754588,0.8658376852428473,0.0008671208063046559
85302,SIDM01187,Bortezomib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.4281328,0.1335508,-0.3647609936575197,-0.004153156025151664
11231,SIDM00944,5-Fluorouracil,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,52.74992395704158,4.253399,0.25514904,0.053731424862141684,-0.004153156025151664
18502,SIDM00878,Vorinostat,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.0000964,-0.03929149,-0.38823575752134454,-0.004153156025151664
97340,SIDM01002,Paclitaxel,Taselisib,Breast,1.0,Breast Carcinoma,Female,White,46.0,-0.14259143,-0.014487398,-0.4112022442131501,-0.004153156025151664
79919,SIDM00881,Gemcitabine,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,49.0,-0.77091753,-0.02962341,-0.1995198533689969,0.0049064349277283875
36193,SIDM00455,Paclitaxel,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.267548,0.0679669,-0.18125428104930683,0.0012187233762596826
50317,SIDM01139,OSI-027,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Female,White,70.0,3.0148258,0.19841552,1.2334461035077882,0.0008671208063046559
46192,SIDM00881,GSK269962A,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,49.0,2.5857406,0.04137274,2.377940346603094,0.0012187233762596826
26582,SIDM00893,Temozolomide,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.5006981,0.135717,0.4748176336698837,-0.004153156025151664
104354,SIDM00531,Irinotecan,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.1572819,0.0845345,0.40176773812461714,0.0012187233762596826
55003,SIDM00866,NU7441,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-1.4150122,-0.025312373,-0.7467023250045449,-0.00450475859510669
76131,SIDM00892,Vorinostat,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,23.0,-0.44113213,-0.0403994,-1.007961724418249,-0.004153156025151664
26910,SIDM00534,Olaparib,MK-2206,Large Intestine,10.0,Colon Carcinoma,Unknown,Unknown,52.74992395704158,2.296908,0.03977575,0.8497880182261,0.0008671208063046559
74410,SIDM00301,MK-1775,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.072135,-0.03376396,0.5952613826103811,-0.004153156025151664
67592,SIDM00940,Doramapimod,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,43.0,1.9626704,0.12675169,0.413362941059637,0.0012187233762596826
41908,SIDM00241,Crizotinib,MK-2206,Breast,0.25,Breast Carcinoma,Female,East Asian,53.0,-2.7390184,-0.09667731,-1.4550952914219626,0.0008671208063046559
98127,SIDM00118,AZD8055,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.6040571,0.054705344,2.1484056648748537,0.0249215129143481
69134,SIDM00899,Taselisib,Linsitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Female,White,62.0,0.45837677,0.045357525,-0.7207512855149377,-0.004153156025151664
100046,SIDM00359,Trametinib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0132158,-0.08458069,-0.4274183142573643,-0.0006810030359088663
34500,SIDM00954,GSK269962A,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.0,2.9796937,0.047283664,0.9302716738122929,-0.004153156025151664
69750,SIDM00411,Oxaliplatin,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.5252794,0.11534838,-0.3882593310143801,-0.004153156025151664
92997,SIDM00531,Olaparib,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.2548021,-0.0751885,-0.12571096245960237,0.0008671208063046559
29178,SIDM00681,Vinorelbine,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,54.0,1.0653411,0.07631497,-0.2473093471453695,-0.004153156025151664
61788,SIDM00885,Ribociclib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,41.0,0.92936957,0.021752955,2.9669237620035127,0.0008671208063046559
64645,SIDM00664,Irinotecan,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,White,46.0,-2.350612,-0.14122914,-0.9939920240013577,-0.0006810030359088663
87607,SIDM00872,Pictilisib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.514033,-0.05221295,-0.9406279649432164,-0.004153156025151664
12973,SIDM00950,Ruxolitinib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.9832125,-0.048424527,-0.22683337958682848,0.0012187233762596826
952,SIDM00628,Bortezomib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.46116677,0.04222838,0.20135793658286483,-0.0010326056058638932
85456,SIDM00528,PD173074,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,40.0,-0.6114874,-0.03703807,0.3341289284889068,-0.0004654444736829603
10029,SIDM00874,Doramapimod,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,23.0,-1.5068026,-0.07790766,-0.19066190073874348,-0.004153156025151664
28246,SIDM00938,NU7441,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,58.0,-1.4835541,-0.119924545,-1.0515883907258405,-0.00450475859510669
33716,SIDM00954,Docetaxel,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,1.0575882,0.03458688,0.765427005673568,0.0008671208063046559
17843,SIDM00241,Docetaxel,Linsitinib,Breast,10.0,Breast Carcinoma,Female,East Asian,53.0,5.706772,0.25155184,0.07693386807698883,-0.00450475859510669
76146,SIDM01186,Sorafenib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,57.0,1.8504137,0.061985154,-0.26405052390840145,0.0008671208063046559
78052,SIDM00332,Venetoclax,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.1758213,-0.08867681,1.7445009336017756,0.007858728252343744
107515,SIDM00314,Venetoclax,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,1.2673341,0.03291703,0.7179136609646977,0.0008671208063046559
18226,SIDM00135,AZD8055,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.16686977,-0.00893045,-1.5802264658224303,-0.00450475859510669
86049,SIDM00118,AZD8055,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.6291965,-0.10291589,-0.05204560197105676,-0.004153156025151664
46362,SIDM00950,5-Fluorouracil,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.6114457,0.1538052,0.38103635632707195,0.0012187233762596826
9905,SIDM01136,Irinotecan,SCH772984,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,85.0,-0.6846876,-0.017778829,0.8169633915108194,0.0249215129143481
28983,SIDM00453,Gemcitabine,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,64.0,-1.2450017,-0.019751929,-0.6178449752284839,0.0008671208063046559
67713,SIDM01042,NU7441,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5266127,0.040411953,-0.18568420588933138,-0.00450475859510669
94809,SIDM01233,MK-2206,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-3.5229895,-0.1926,-1.7954639587977697,-0.004153156025151664
98392,SIDM00629,Wee1 Inhibitor,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,43.0,0.75621235,0.023729762,0.6451811340555602,0.0012187233762596826
58773,SIDM01002,Bortezomib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,White,46.0,-0.9635877,-0.086725906,-0.5403173521446363,-0.00450475859510669
76640,SIDM00783,AZD4547,Afatinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,52.74992395704158,-0.08470925,-0.0061177886,1.430197967059244,-0.004153156025151664
19570,SIDM01188,Olaparib,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,White,57.0,0.7405779,0.033782583,0.06438526695682288,0.0012187233762596826
25583,SIDM01056,Tozasertib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,50.0,-1.1294872,-0.11501335,-2.9484641113617513,-0.004153156025151664
68855,SIDM00879,AZD8055,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,32.0,-6.457262,-0.03381756,-1.573904610503409,-0.0004654444736829603
103054,SIDM00681,LGK974,SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,54.0,1.2903198,0.04499134,1.752351751825825,0.0012187233762596826
43336,SIDM00132,Sorafenib,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Female,Unknown,61.0,1.1099558,0.062237646,-0.9548931837606264,-0.004153156025151664
105463,SIDM01187,Temozolomide,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.374766,-0.07843582,-1.2600313386490805,-0.00450475859510669
106561,SIDM00832,Crizotinib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,81.0,0.8263394,0.08077686,2.103734441207311,0.02082694692184988
97628,SIDM00920,Nilotinib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.9524433,-0.0883265,-0.7425474080312956,-0.004153156025151664
34881,SIDM00332,NU7441,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.29963043,-0.017124064,-0.0017326499587914648,0.0008671208063046559
63550,SIDM00122,Ribociclib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,72.0,-1.4554075,-0.044348422,0.3733526011062751,0.0008671208063046559
68282,SIDM00884,Docetaxel,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,43.0,-0.53354394,-0.04814755,0.38313488191056005,-0.004153156025151664
80210,SIDM00928,Luminespib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,2.4774156,0.15341823,0.9499543286985274,0.0012187233762596826
55435,SIDM00963,JQ1,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,60.0,-1.1426109,-0.10002904,-0.6821006029324967,-0.004153156025151664
78464,SIDM00954,AZD8055,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,0.81493527,0.08697948,0.04431866370573411,-0.004153156025151664
29523,SIDM00670,Olaparib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,White,64.0,2.0706875,0.036852527,0.23884146421918692,-0.0004654444736829603
48559,SIDM01056,KU-55933,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,50.0,-2.1707964,-0.108808696,-1.5083703944440445,0.0008671208063046559
24184,SIDM00122,Wee1 Inhibitor,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,72.0,0.860688,0.011854753,-0.38241557918077673,-0.004153156025151664
67122,SIDM01042,Axitinib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.0069585,-0.30115116,-2.1602499904709385,-0.00450475859510669
72492,SIDM00664,Ruxolitinib,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,White,46.0,0.97232676,0.12860726,-0.05351760498076506,-0.00450475859510669
60983,SIDM00933,Temozolomide,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,3.6035624,0.3236045,2.4712549172890186,-0.00450475859510669
53615,SIDM00934,SCH772984,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,40.0,5.4211183,0.31963614,2.145938657896242,0.0012187233762596826
98542,SIDM00583,Taselisib,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,56.0,-0.40283692,-0.014289441,0.37220281974754604,-0.004153156025151664
42043,SIDM00241,Nutlin-3a (-),Gemcitabine,Breast,0.01,Breast Carcinoma,Female,East Asian,53.0,-0.31515995,-0.018624904,-1.0967877892598277,0.0012187233762596826
91692,SIDM00875,Linsitinib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6114239,0.057028558,0.3317570629564702,0.0012187233762596826
59253,SIDM00146,Pictilisib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.26400104,0.021757688,-0.14480088295807972,0.0012187233762596826
2230,SIDM00782,AZD7762,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,1.3399447,0.10420982,-0.1344913043610714,0.0008671208063046559
5420,SIDM00042,Sorafenib,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.19536628,0.014021134,-1.20466460458749,-0.0004654444736829603
60360,SIDM00812,Camptothecin,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,53.0,1.2495015,0.036051862,0.14340718519834633,0.0012187233762596826
43043,SIDM01056,Nutlin-3a (-),AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,50.0,1.1694967,0.09275386,-0.1947267066747697,-0.00450475859510669
43490,SIDM00314,Palbociclib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,63.0,-1.5350446,-0.09331154,-0.6028681123840374,-0.004153156025151664
18891,SIDM00660,Navitoclax,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-0.83164644,-0.089298196,-0.2178608334077899,-0.00450475859510669
58610,SIDM01037,Nilotinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,62.0,-1.6392965,-0.046805557,-0.6778356063157518,0.0012187233762596826
64591,SIDM00132,Gemcitabine,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Female,Unknown,61.0,-1.1998847,-0.039279398,-0.729113804467298,-0.004153156025151664
47269,SIDM00866,Ribociclib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-3.3502045,-0.14067902,-0.7523593603759058,-0.0006810030359088663
98390,SIDM00628,Trametinib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-1.7018175,-0.13930722,-0.14748792642603578,-0.004153156025151664
96423,SIDM00882,Axitinib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Other,42.0,1.056847,0.10279813,0.33926976056357294,-0.004153156025151664
30704,SIDM00971,Tozasertib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.085489,0.12524171,3.021261113941903,0.0012187233762596826
40120,SIDM00933,Lapatinib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.66625166,-0.022813454,0.24371447117452943,0.0012187233762596826
29338,SIDM00957,MK-1775,Linsitinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-2.7255492,-0.160264,-1.73951633625133,0.0008671208063046559
108447,SIDM00531,Linsitinib,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.7437973,0.08226139,-0.42438901639143745,0.0008671208063046559
55983,SIDM01138,Paclitaxel,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,White,65.0,-1.7652088,-0.05429292,-0.9436917930830487,0.0008671208063046559
12103,SIDM00487,MK-1775,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,Unknown,52.74992395704158,3.46528,0.15439796,1.190953284732606,0.0012187233762596826
14914,SIDM00963,Afatinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,60.0,1.6161332,0.014641362,0.9161582022148421,-0.004153156025151664
45198,SIDM00272,Uprosertib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,48.0,-1.0893028,-0.10121567,-0.4054127628091169,-0.0004654444736829603
12411,SIDM00898,BI-2536,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,43.0,2.602247,0.07310282,0.27238199030902477,-0.0004654444736829603
44102,SIDM00789,5-Fluorouracil,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,52.74992395704158,0.5167686,0.041735064,0.7445311218231682,0.003006708515559838
22678,SIDM00885,Nutlin-3a (-),MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,41.0,2.5759096,0.2052098,1.0423798136720228,0.02082694692184988
77184,SIDM00878,RO-3306,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-2.6632175,-0.0871037,-1.3655949464254098,0.0012187233762596826
99893,SIDM00135,MK-2206,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.8463964,-0.0983001,-0.7509731344504139,0.0012187233762596826
82965,SIDM00943,Paclitaxel,Erlotinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,56.0,-4.921332,-0.24159299,-2.377546346371553,-0.00450475859510669
27811,SIDM00899,SCH772984,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Female,White,62.0,-2.301081,-0.048748367,-0.12017046766425103,-0.0004654444736829603
35196,SIDM00839,Dabrafenib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,56.0,3.6406448,0.15293124,0.7077531007921413,-0.004153156025151664
80863,SIDM00885,Tozasertib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,41.0,0.92057997,0.038643774,1.7669772094382494,0.0049064349277283875
64006,SIDM00971,BI-2536,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.9630611,0.12706836,-0.01142430886123333,0.0012187233762596826
91705,SIDM00118,5-Fluorouracil,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.19815601,-0.016020833,0.012327593773489638,-0.00450475859510669
23942,SIDM00097,5-Fluorouracil,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.19768938,-0.0063704243,0.13517977166960127,0.0012187233762596826
38981,SIDM00885,OSI-027,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,41.0,-1.5697094,-0.07527621,0.47554565364345414,-0.004153156025151664
2981,SIDM00498,Nutlin-3a (-),BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Female,East Asian,77.0,-0.13163798,-0.012203997,-0.8098962422248457,-0.004153156025151664
